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ABSTRACT 
 
Investigations on the Mechanism of Allosteric Activation of Rabbit Muscle Glycogen 
Phosphorylase b by AMP. (May 2009) 
Andrew Nathan Bigley, B.S., University of Houston Clear Lake 
Chair of Advisory Committee: Dr. Gregory D. Reinhart 
 
 Much work has been carried out on glycogen phosphorylase over the last seventy 
years. Interest has persisted due not only to the usefulness of phosphorylase as a model 
system of allostery, but also due to the connection to the disease state in type II diabetes. 
The bulk of research consists of structural studies utilizing the wild-type enzyme from 
rabbit muscle. In this study we have employed linkage analysis in combination with 
structural perturbations via site-directed mutagenesis to test kinetic models of activation 
of phosphorylase b by AMP, and to examine the roles of the N-terminus, the acidic 
patch, α-helix 1 and the 280’s loop in activation by AMP. Experiments have been 
carried out on purified glycogen phosphorylase b variants to determine the effects of 
perturbations in vitro.  
 The kinetic models of activation by AMP are found to be a relatively accurate 
description of kinetic behavior of wild-type phosphorylase b, but are found to be 
technically incorrect with respect to the absolute requirements of two equivalents of 
AMP to be bound prior to catalysis. Phosphorylase b demonstrates activity in the 
absence of AMP, though only at high concentrations of phosphate, and a hybrid 
iv 
phosphorylase b with only a single functional AMP binding sight shows slight 
activation.  
 The truncate ∆2-17 shows weakened binding to AMP and phosphate in the apo 
enzyme, but maintains activation by AMP to an affinity similar to that of wild-type, 
indicating that the N-terminus is not required for activation by AMP, but has a role in 
establishing the affinity for both AMP and phosphate in the apo enzyme. Perturbations 
of the acidic patch indicate that interactions between the acidic patch and the N-terminus 
enhance the affinities in the apo enzyme, suggesting that the structures of the N-terminus 
at the acidic patch may represent an active form of the enzyme. α-helix 1 is found to 
have a role in homotropic cooperativity in phosphorylase b, but not in heterotropic 
activation by AMP, while the 280’s loop is confirmed to have a role in the heterotropic 
coupling between AMP and phosphate.  Based on the findings in this study an alternate 
structural model of activation by AMP involving α-helix 8 is proposed.  
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NOMENCLATURE 
Phosphorylase b Unphosphorylated glycogen phosphorylase 
Phosphorylase a Glycogen phosphorylase phosphorylated at serine 14 
Phosphorylase b’ Glycogen phosphorylase with residues 1-16 removed via  
   limited proteolysis 
∆2-17   Glycogen phosphorylase from truncated phosphorylase gene 
   with start codon at position 17 
N-terminus  Residues 1-22 of glycogen phosphorylase 
NADP(H)  Nicotinamide adenine dinucleotide phosphate  
AMP   Adenosine-5-monophosphate 
PMSF   Phenylmethylsulfonyl fluoride 
PAGE    Polyacrylamide gel electrophoresis  
SDS   Sodium dodecylsulfate  
EDTA   Ethylenediaminetetraacetic acid 
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CHAPTER I 
INTRODUCTION: A BRIEF HISTORY OF GLYCOGEN 
PHOSPHORYLASE AND ITS CURRENT RELEVANCE 
 
  
 The most extensively studied isozyme is phosphorylase from rabbit muscle (2). In 
the muscle, phosphorylase requires activation for significant activity to be observed 
(1,5). Activation can come in the form of allosteric activation by AMP or by covalent 
activation by phosphorylation of serine 14 (1,2). The unphosphorylated form is identified 
as phosphorylase b while the phosphorylated form is phosphorylase a. Phosphorylase a 
is further activated to a small degree by the addition of AMP (4). Physiologically, both 
forms of phosphorylase are inhibited competitively by glucose and allosterically by ATP 
Glycogen phosphorylase catalyzes the breakdown of glycogen stores via 
phosphorolysis to liberate glucose-1-phosphate (1). Phosphorylase has been conserved 
across the spectrum of life with homologues identified in mammals, yeast, slime mold, 
plants and bacteria (2). Generally, the properties of the catalytic core of the enzyme are 
maintained, but the regulation varies dramatically among species (2). In the mammalian 
system there are three isozymes; muscle, liver, and brain named for the tissue where they 
predominate (3). The biological roles of each differ along with their regulation (4). In the 
muscle and brain the glucose-1-phosphate is shuttled into glycolysis to provide energy 
for cellular function while in the liver glucose-1-phosphate is converted to glucose to 
maintain blood sugar (2,4).  
____________ 
  This dissertation follows the style of Biochemistry. 
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(1, 6,). Phosphorylase b is also allosterically inhibited by the downstream product 
glucose-6-phosphate (1,7). Inhibition has also been shown in vitro with various purine 
analogs including FMN, caffeine and at high concentrations AMP. In addition, 
phosphorylase b can be activated in vitro with high concentrations of sulfate (1,8,9,10). 
 Structurally, glycogen phosphorylase is a dimeric enzyme with a subunit 
molecular weight of 97.5 kDa, though an inactive tetramer is known to form in vitro 
(2,11) (Figure 1.1). Each subunit can be roughly divided into an N-terminal regulatory 
domain (residues 1-348) and a C-terminal catalytic domain (residues 349-832) (2). 
Phosphorylase has five sites thought to interact with each other. The active site sits in a 
cleft between the domains of the subunit and contains the cofactor required for catalysis, 
pyridoxal-5-phosphate (1,2,12). Access to the active site is thought to be controlled by 
the 280’s loop (residues 280-286), which appears bound at the active site cleft in inactive 
structures (2,13,14).  The purine inhibition site that binds aromatic inhibitors lies 
between tyrosine 613 of the C-terminal domain and phenylalanine 285 of the 280’s loop 
resulting in the closing off of the active site when an inhibitor is bound (9). The glycogen 
storage site is thought to hold the enzyme to the glycogen particle in vivo, and there is 
some structural evidence that binding is an activating event (15). The remaining two 
sites, the allosteric site, where the activator AMP and the inhibitors ATP and glucose-6-
phosphate bind, and the phosphoserine recognition site, are located along the interface 
between the subunits (13). The subunit interface is made up of two sets of interactions, 
the α-helix 1 and 2 bundle and the tower helices. Both the allosteric site and  
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Figure 1.1: Dimeric structure of glycogen phosphorylase b activated by AMP. Subunit 1 is colored 
light grey. Subunit 2 is colored dark grey. Only subunit 2 is labeled for clarity. α-helices 1 and 2 are 
shown in blue for subunit 2 and pink for subunit 1. Tower helices are shown in yellow. Active site 
cofactor is shown in green. AMP bound to allosteric site shown in red. N-terminus is shown in 
forest green. Structure from Protein Data Bank entry 1pyg. Figure prepared with UCSF Chimera 
software from the Resource for Biocomputing, Visualization, and Informatics at the University of 
California, San Francisco (supported by NIH P41 RR-01081). 
Active site 
AMP 
α-helix 1 
α-helix 2 
Acidic patch 
Tower helix 
Glycogen storage site 
Purine inhibition site 
(active site cleft) 
N-terminus 
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the phosphoserine recognition site are located on one side of the interface made up of 
interactions between α-helix 1 (residues 23-35) and α-helix 2 (residues 48-78) and the 
loop that connects them (the cap loop, residues 35-47) (13) (Figure 1.1). Though the sites 
are separated by approximately 15Å, both the allosteric site and the phosphoserine 
recognition site involve residues from α-helix 2 and residues from the cap loop of the 
opposing subunit. The opposite side of the subunit interface is made up of the 
interactions of α-helix 7 with its counterpart from the other subunit.  
 Glycogen phosphorylase was the first case of allostery discovered and the first 
case of regulation by phosphorylation (8,13). The study of glycogen phosphorylase has 
extended beyond seventy years now, and an appreciation of the historical context under 
which the knowledge of phosphorylase has been developed through the years is helpful 
in understanding the questions yet to be resolved. 
 
A BRIEF HISTORY OF PHOSPHORYLASE 
  The study of glycogen phosphorylase has spanned the development of 
biochemistry as a discipline and served as a basis for the development of many of the 
theories currently in use. Glycogen phosphorylase activity was discovered in extracts of 
rabbit muscle in 1936 (16). Shortly thereafter, the same activity was found in extracts of 
various tissues, and the effect of AMP on this activity was noted (16,17). This 
unexplained observation was the first report of allostery. Throughout the remainder of 
the 1930’s studies of this activity in extracts continued with the effects of metals, pH, 
and product inhibition being examined (18). Before the end of the decade the same 
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activity was also reported in peas and potato extracts, and the reversibility of the reaction 
was discovered (5).  
 The 1940’s brought about the recognition of DNA as the material of genes, and 
glycogen phosphorylase was first purified in 1943 (5,19). During this study, two forms of 
phosphorylase in the muscle extracts were found, only one of which was being purified. 
The two forms of phosphorylase were found to differ significantly in their response to 
AMP (5). To distinguish the two forms of the enzyme they were identified as the a and b 
forms of the enzyme with the b form being more dependent on AMP for its activity. 
Researchers identified the apparent conversion from the a form to the b form if care was 
not taken during the purification (5). This interconversion was identified as being 
dependent on an enzyme in 1945 (20).  
 The 1950’s ushered in major advances in protein science with the identification 
of the α-helix and β-sheet as secondary structural elements (19). In phosphorylase 
research, experiments using limited proteolysis of phosphorylase a gave rise to a 
phosphorylase (phosphorylase b’) that was distinct from both phosphorylase a and b 
(21). Fischer and Krebs reported in 1956 that they had partially purified phosphorylase b 
as well as an enzyme capable of converting it to phosphorylase a (22). That same study 
also found that the conversion from b to a was due to phosphorylation of the b form in 
the first case of protein phosphorylation to be reported. That same year, conditions were 
found to dissociate phosphorylase, allowing the identification of phosphorylase a as a 
tetramer and phosphorylase b as a dimer (23). The following year the cofactor of 
glycogen phosphorylase was identified as pyridoxal-5-phosphate (12). Shortly thereafter 
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the role of the cofactor in phosphorylase was shown to be different from the role 
observed in other enzymes by demonstration that the Schiff’s base formed was 
unimportant to catalysis (24). 1958 brought about the first complete purification of 
phosphorylase b along with its crystallization (25). The 1950’s drew to a close with the 
first structure of a protein being solved, myoglobin, by Kendrew in 1959 (19), and the 
sequence of the phosphorylated peptide from phosphorylase a was identified by the new 
technique of protein sequencing (26). 
 The 1960’s saw major advances and the studies of allostery. In particular, the 
recognition that globular proteins have regular, definable structures led to proposals on 
how structure might lead to allostery. First, was the proposal by Monod, Wyman and 
Changex of the concerted model of allostery (MWC model) that requires molecular 
symmetry in multimeric enzymes (27). Shortly thereafter, Koshland, Nemethy, and 
Filmer proposed the alternate sequential model (KNF model) (28,29). Both of these 
models held that the allosteric properties were derived from the existence of two unique 
structures, the inactive T-state and the active R-state, and that the equilibrium between 
them defines the allostery. Phosphorylase, which shows both homotropic cooperativity 
(the binding of one ligand effecting the binding of subsequent identical ligands) and 
heterotropic coupling (the binding of one ligand effecting the binding of a different 
ligand), was one of the cases considered in the development of the MWC model, and the 
MWC model was soon applied to explain the observations being made in phosphorylase 
research (6). Later in the 1960’s the inhibition by ATP and glucose-6-phosphate was 
discovered along with the activating effects of polyamines (7,30). The dimer of glycogen 
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phosphorylase was found to be the active species rather than the tetramer as had been 
presumed due to the isolation of phosphorylase a in a tetrameric form (11). In 1968 one 
of the most influential studies of phosphorylase to date was published (31). In this study, 
the enzyme species generated by limited proteolysis (phosphorylase b’) was studied in 
detail, and it was shown that phosphorylase b’, while requiring AMP, did not show the 
activation normally observed with phosphorylase b, and there was a loss of all 
homotropic cooperativity in binding the substrate phosphate and effector AMP. In light 
of the new models of allostery, it was proposed that the peptide removed by limited 
proteolysis was responsible for the transmission of the allosteric signal across the 
interface. The findings of the study of phosphorylase b’ would later form the bases of the 
structural understanding of phosphorylase activation. 
 Studies on the catalytic mechanism, the dimer/tetramer equilibrium, and the 
nature and role of the glycogen particle continued into the 1970’s (15,32,33). 
Experiments revealed that phosphorylase remained bound to the glycogen particle as did 
phosphorylase kinase and phosphatase (34). By 1970, it was recognized that glycogen 
phosphorylase in the liver has a role in the regulation of blood sugar (35), and later that 
there were different isozymes that were prevalent in different tissues (3).  
 In the field of phosphorylase allostery, numerous major advances were made in 
the 70’s. In 1970, the sites for AMP and glucose-6-phosphate were shown to be at least 
partially overlapping (36). Studies were conducted to test the AMP site using 
synthetically derived inhibitors to determine what made the site specific for AMP (37). 
One of the first problems with using two-state models to describe allostery in 
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phosphorylase was reported in 1970. It was found that phosphorylase modified with 
glutaraldehyde to stabilize the structure was still responsive to AMP activation, but that 
there was no homotropic cooperativity in the binding of AMP as was called for by the 
MWC model (38).  
 1976 ushered in the first high resolution structures of phosphorylase a though the 
model built initially only gave the backbone positions (39). Later that year, it was shown 
that phosphorylase was active in the crystalline state, though at much reduced levels of 
activity (40). This finding was taken as evidence that the structure observed in the solved 
crystal structures was relevant to the physiologically active enzyme. The following year, 
the complete sequence of the muscle phosphorylase protein was published allowing the 
generation of true high resolution crystal structures (3Å) and the unambiguous 
identification of the N-terminus as the site of phosphorylation (41,42,43). The two-state 
models of allostery continued to be applied to phosphorylase, and as structures of both 
phosphorylase a and b appeared, the unique structures seemed to confirm the theory 
(39,44,45). The structure solved with maltopentose identified the site of attachment to 
the glycogen particle, as well as the fact that binding of the polysaccharide altered the 
structure of phosphorylase from that seen in the unbound structures (15). The study of 
polysaccharide binding also presented the first complex kinetic scheme of how 
phosphorylase might be allosterically activated. Caffeine was first recognized as an 
inhibitor of phosphorylase in 1978, and newly generated structural data allowed the 
identification of its binding site, later referred to as the purine inhibition site (9,10). 
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 Structural work continued in earnest in the 1980’s with more and more structures 
being generated with activators or inhibitors bound (46,47,48,49). The comparison of the 
differences in these structures allowed early attempts to explain the structural mechanism 
of allosteric activation in phosphorylase (14,47,49,50). The 80’s also saw the first 
reported T-state structures of phosphorylase b and a, and the more difficult to generate 
R-state of phosphorylase b (14,46,48,51).  
  The 80’s also brought great advancements in the sequence data available. More 
protein sequences were solved, and the advent of PCR allowed the DNA sequences to 
provide information from more organisms (19,52,53,54,55). This new information fueled 
a great deal of effort to understand the evolutionary relationships among species in the 
hope that understanding the relationships would provide insight on the regulation of the 
enzyme (52,56). The most important finding was that the catalytic core of phosphorylase 
was conserved, while the N-terminal 150 residues were highly variable and appeared to 
give rise to the unique regulation seen in each homolog. 
 The early 1990’s held major advances for phosphorylase research. The chemical 
mechanism of phosphorylase was elucidated, though it would be in the late 90’s before 
transition state analogs would finally remove any doubts that catalysis proceeds through 
a carbocation mechanism (57,58,59). Sulfate activation of phosphorylase b was studied 
in detail in 1990 (60,61). It would later be shown that sulfate activation was due to an 
interaction with the N-terminus (62). The two-state models were used to try to provide a 
uniform description of allostery in diverse systems through structural comparisons of 
other allosteric enzymes (63). This was in part due to the identification of a proposed 
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switch of residues R569 and D284 in the active site between the R- and T-states of 
phosphorylase, respectively (57,64).  
 Probably the most influential paper on phosphorylase structure was published by 
Barford and Johnson in 1991 (13). They reported the proposed R- and T-state structures 
of phosphorylase a and b and reviewed all known structural data. This combination of 
information allowed the discussion of the observed structural changes and the proposal 
of how those changes resulted in the propagation of the allosteric signal. The N-terminus 
(residues 1-22) was found bound at the subunit interface in the R-state and at the acidic 
patch in the T-state, which was interpreted to be the conduit for the allosteric signal 
across the interface as had been  postulated from the work done with phosphorylase b’ 
(31). Likewise, the movements of the helices at the subunit interface shown in the 
activated structures, and the disordering of the 280’s loop (residues 280-286) that 
blocked access to the active site in the T-state structures were hypothesized to be 
important for allosteric activation (13). This paper acknowledged numerous problems 
with the limitations imposed by the two-state models of allostery, namely the numerous 
structures showed combinations of both R- and T-states, the ability to uncouple the 
homotropic and heterotropic effects, and the uncertain nature of the position N-terminus 
in phosphorylase b. 
 The early 90’s also held two other major events in phosphorylase research. First, 
the successful expression of rabbit muscle glycogen phosphorylase in a bacterial system 
allowed the ready manipulation of the enzyme (65). Second, inappropriate activity of 
liver phosphorylase was linked to the high blood sugar seen in patients with type II 
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diabetes, which refreshed interest in the regulation of phosphorylase (66,67). The 
bacterial expression system allowed for testing of hypotheses based on structural 
perturbation for the first time, and the new link to a disease state brought about a search 
for inhibitors of phosphorylase (66).  
 Sequence comparisons between the known mammalian and later all known 
phosphorylase enzymes allowed predictions of what residues were important for 
allostery (2,4). Unfortunately, when put to the test those early predictions failed to 
deliver the predicted response (68,67,69). Specifically, residue P48 in muscle was 
predicted to be a switch between the R- and T-states, but when mutated there was a loss 
of homotropic cooperativity but not activation by AMP. Similarly, placing a negative 
charge at position 14 failed to create an enzyme that was active in the absence of AMP as 
predicted (70), and numerous reviewers were led to speculate that the special ionic 
character of the phosphoryl group was the key to its use in signaling (71).  
 Later, a report declared that the molecular activation switch in phosphorylase had 
been identified by engineering a metal binding site at the subunit interface, however in 
reality very little activation was observed, and the enzyme was retained little activity 
(72). Attempts to verify the 280’s loop including aspartate 284 as important for allostery 
met with similar challenges as it was found that phosphorylase did not tolerate changes 
to the 280’s loop (73). Ultimately in 1997, the continued difficulty in using the two-state 
models of allostery for phosphorylase led to the publishing of a continuous model of 
allostery in phosphorylase b to account for observed kinetics (74). The 90’s drew to a 
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close with full scale efforts under way to generate inhibitors for the treatment of diabetes 
and to understand the complex regulation of glycogen metabolism in the liver (75).  
 Much the same efforts continued into the new century with a second continuous 
kinetic model of allostery being published for phosphorylase (76,77), and many more 
structures being published with inhibitors being bound to various sites 
(78,79,80,81,82,83). Reports on the effects of complex mixtures of physiological 
inhibitors and activators were published in an attempt to understand the regulation in the 
liver (84,85). Interest in glycogen phosphorylase has been maintained as of late by the 
continued efforts to develop therapeutic inhibitors, a search that has been complicated by 
the finding that the liver enzyme must be specifically targeted (86), and the discovery 
that there is a shunt from glycogen to the formation of numerous sugar moieties of 
glycoproteins (87). A recent study of phosphorylase has further highlighted the 
deficiencies in the current understanding of phosphorylase. This modeling study 
predicted that phosphorylase must have a minimum of three structural states to explain 
the existing kinetic data, and the authors postulate that the true active form is yet to be 
solved (88).  
 
THE GENERALLY ACCEPTED STRUCTURAL MODEL OF ALLOSTERY IN 
GLYCOGEN PHOSPHORYLASE 
 Despite the aforementioned difficulties, the various structures with activated and 
inhibited phosphorylase that have been solved over the years have led to a proposed 
model of activation (1,13,63). It is generally accepted that the mechanism of activation is 
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the same for activation by both AMP and phosphorylation. The major differences 
between the active and inactive states that are thought to be important for activation 
involve the conformation of the interface, the movement of the N-terminus from the 
acidic patch (residues 96, 105, 109, 110, 120, 493, 501, 505, 509) to the interface, and 
the displacement of the 280’s loop (1,13) . It is proposed that the binding of AMP to the 
allosteric site causes a shift in α-helix 2 and brings the cap loop of the other subunit into 
proximity of the AMP binding site (13) (Figure 1.2). The N-terminus is released from the 
acidic patch on its own subunit upon activation and moves to the subunit interface. The 
rearrangement of the interface is thought to result in a rotation of the subunits with 
respect to each other causing the tower helix to slide past its counterpart on the opposite 
subunit (8, 13) (Figure 1.3). The movement of the tower helices is proposed to cause the 
displacement of the 280’s loop (residues 280-286) allowing substrate access to the active 
site (1,13) (Figure 1.3). Additionally, the activation of phosphorylase is thought to be 
brought about by the displacement of aspartate 284 from the active site where it is 
proposed to prevent phosphate binding (1,57). The negative charge of the aspartate is 
replaced by the positive charge from arginine 569 which is proposed to create the high 
affinity binding site for phosphate in the active enzyme (57). This model is predicted to 
be correct for both the activation by AMP and phosphorylation though minor local 
differences are acknowledged (13). 
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Figure 1.2: Dimeric structure of activated and inhibited phosphorylase b highlighting α-helices 1 and 2, cap loop, 
and N-terminus. Subunit 1 is colored light grey. Subunit 2 is shown in dark grey. α-helix 1 and 2 for subunit 1 are 
shown in pink. α-helix 1 and 2 from subunit 2 are colored in blue. The cap loop connects α-helices 1 to α-helix 2. 
Active site cofactor is shown in green. The N-terminus colored forest green. The tower helices (on the opposite 
face of protein) are shown in yellow. AMP bound to allosteric site is shown in red. A) Inhibitor bound structure 
(PDB 2gpb) with the N-terminus bound to the acidic patch. B) Activator bound structure (PDB 1pyg). Acidic patch 
marked by space-filled side chain of residue 501 in B. Figure prepared with UCSF Chimera software from the 
Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco 
(supported by NIH P41 RR-01081). 
N-terminus 
cap loop 
A B 
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Figure 1.3: Dimeric structure of activated and inhibited phosphorylase b highlighting the tower 
helices and 280’s loop. Subunit 1 is shown in light grey. Subunit 2 is colored dark grey. Tower 
helices are shown in yellow. The helix on right is from subunit 1. The helix on left belongs to 
subunit 2. Tyrosine 613 (purine inhibition site) and 280’s loop are shown in orange (not visible in 
B). The active site cofactor is colored green. A) Inhibitor bound structure (PDB 2gpb). B) 
Activator bound structure (PDB 1pyg). α-helices 1 and 2 on opposite face of enzyme are shown 
in pink (subunit 1) and blue (subunit 2). Figure prepared with UCSF Chimera software from the 
Resource for Biocomputing, Visualization, and Informatics at the University of California, San 
Francisco (supported by NIH P41 RR-01081). 
Glycogen 
storage site 
Glycogen 
storage site A B 
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QUESTIONS REMAINING TO BE ANSWERED 
  After more than seven decades of research, major questions still remain about the 
regulation of mammalian glycogen phosphorylase. The two-state models of allostery 
have been shown to be inadequate to explain the kinetics of glycogen phosphorylase b 
(1,13,57,68). The extensive use of these models throughout the study of phosphorylase 
have influenced the type of data collected. Typically, kinetic data have been collected 
over narrow concentration ranges, and the analysis limited to whether the R- or T-state 
had been stabilized (31,73,89). The continuous models of phosphorylase b allostery were 
derived exclusively using wild-type data, and both contain the surprising requirement 
that two equivalents of AMP bind before catalysis takes place (74,75,76). To date these 
models have not been experimentally tested. 
 The structural changes brought about by phosphorylation are well understood 
along with the kinetics of phosphorylase a (13,47,90). The phosphoserine recognition 
site has been structurally defined and confirmed by mutagenesis (13,89). The regulation 
of phosphorylase b has remained more elusive. The accepted active state of the enzyme 
is based on phosphorylase a, which was solved as the inactive tetramer, and there is no 
dimeric structure of activated phosphorylase (13,47). Further complicating the structural 
evaluation of phosphorylase is the evidence that interaction with the glycogen induces 
changes to the structure which are thought to help activate the enzyme (1, 15). The 
kinetic data on the allosteric activation of phosphorylase are by necessity generated in 
the presence of polysaccharide, but the affects of allosteric effectors on the 
polysaccharide bound structure are unknown (1).  
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 Even with the rabbit muscle enzyme the effects of AMP binding are unclear. The 
limited attempts that have been made to identify the roles of various structural units by 
modification of protein sequence have met with limited success (68,69,70,72,73,89). An 
attempt to verify the proposed role of α-helix 2 in activation by AMP by site directed 
mutagenesis was not successful and pointed to a role only in the homotropic 
cooperativity in AMP binding (68). The packing of α-helix 1 is known to change 
between the reported R- and T-states but its role in the activation by AMP has not been 
investigated (13). The 280’s loop is proposed to be critical in activation (13, 14), but 
difficulties in working with the 280’s loop have failed to verify a role in activation by 
AMP (73). The role proposed for the N-terminus in AMP activation is based on enzyme 
exposed to proteolysis, and ambiguity remains with respect to its localization in active 
phosphorylase b (13,31).    
 
THE MODERN STUDY OF ALLOSTERY 
 Glycogen phosphorylase started the study of allostery, but it was nearly thirty 
years later that the first theories of allostery were developed (16,27,28,29). Those first 
theories were derived from the concept that proteins have constant structures, and that 
those structures dictate the function of the protein in question (19). The concept proposed 
by Monod, Wyman, and Changeux was that an enzyme might have two related but 
different structures each with its own properties giving rise to the phenomenon of 
allostery (27). The MWC model proposed that molecular symmetry must be maintained 
allowing the binding of a single ligand to alter the structure of all subunits giving rise to 
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the observed allostery. Among the arguments for this were the findings that allosteric 
enzymes tended to be multimeric and that homotropic and heterotropic properties 
appeared to be linked in these enzymes; that is, an effector that activated tended to 
alleviate the homotropic cooperativity in substrate binding (27). Given the limited data 
that were available at the time, the MWC model explained the observations made in 
allosteric systems. 
 The model put out shortly thereafter by Koshland, Nemethy, and Filmer adopted 
the same general concept, but argued that the case need not be as simple as that proposed 
in the MWC model in that the molecular symmetry, while favored, need not be strictly 
maintained (28,29). The real drawback to both of these models is the requirement to 
assume a two-state system and applying that assumption to the experimental data rather 
than letting the data dictate the model. The advantages of these models were that they 
could explain most kinetic data being generated, and they allowed the prediction of the 
general behavior of the systems being studied. As structural data were generated for the 
allosteric systems, the finding that allosteric enzymes could exist in different forms 
depending on whether they were activated or inhibited seemed to confirm the concept of 
the two-state models (13,19,91).  
 In the modern era, problems have been found in the two-state models. Work such 
as that by Di Cera on thrombin has been of particular interest because thrombin is a 
monomeric protein meaning that by definition the two-state models, which are derived 
for multimeric enzymes, cannot be applied (92,93,94). The work on thrombin and other 
monomeric allosteric proteins has led to a reevaluation of how allosteric signals might be 
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propagated. Ernesto Freire has proposed that the nature of the two-state models is too 
restrictive and in reality there is an ensemble of structures some competent to bind and 
others not, and through local perturbations of folding states ligands can alter the 
ensemble to bring about the allosteric nature of the system (95). Others have looked to 
protein dynamics as the source of allostery, holding that the change in dynamics brought 
on by ligand binding is responsible for the alteration of properties (96). Both of these 
concepts hold the potential that only a small subset of interactions in the protein may be 
responsible for the communication between sites. The identification of these interactions 
has become a major effort, and structural studies with thrombin have been successful in 
elucidating the pathway of communication between the allosteric site and active site 
(93,94).  
 Thrombin remains the only allosteric enzyme for which a defined pathway has 
been identified, but identification efforts in other systems have been helped by new 
analysis techniques. Protein covariation analysis developed by Ranganathan has proven 
to be able to pick out apparent pathways connecting sites in various proteins that have 
been conserved through evolution (97). A modeling approach that maps the secondary 
and tertiary interactions that change in reported R-and T-states of various allosteric 
enzymes has been developed by Gray and shown to highlight apparent pathways of 
communication between sites (98) . Unfortunately, the attempt to model such structural 
changes in phosphorylase failed to identify such a pathway. Similarly, covariation 
analysis is not likely to succeed in phosphorylase due to the need for a large number of 
related sequences to statistically identify residues that are evolutionarily covariant (97). 
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The mammalian enzymes are thought to have developed their regulation via a fusion at 
the N-terminus, meaning that the N-terminal region is only conserved among mammalian 
species, which severely limits the application of covariation analysis (2). 
 As early as the 70’s, Weber called out the warning to the scientific community 
that attempting to explain allostery simply by a two-state structural model comes at the 
cost of understanding the kinetic and thermodynamic data available for these systems 
(99,100). Adopting the two-state models greatly simplified the analysis of allosteric 
systems for early researchers, but it requires the assumption of a model that may or may 
not be correct.  Weber developed formalisms to deal with allostery on a purely 
thermodynamic basis without making assumptions to the nature of the system, but the 
two-state models continued to be widely accepted (99,100).  
 The approach of Weber was continued and further developed by Reinhart to be 
applied to a symmetrical dimer including both the theory and experimental approach to 
test the extent of coupling (101). Similarly, Ackers took a statistical thermodynamics 
approach to attempt to resolve in finer detail the nature and magnitude of the allosteric 
communications in his system of interest, hemoglobin (102). Both approaches, referred 
to as linkage analysis, provide detailed descriptions of the behavior of the allosteric 
systems, but alone they do not provide insight on how the allostery is structurally 
transmitted.  
 De Cera has pointed out in recent years that the data collected via crystallography 
can be constrained by the crystal lattice itself either obscuring small but important 
movement or emphasizing irrelevant movements, and structural work itself must be 
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validated (94). Utilization of thermodynamic linkage allows the testing of hypotheses on 
how allosteric signals might be transmitted based on the available structural data. Three 
of the most influential systems considered in the development of the two-state models 
were phosphorylase, PFK, and hemoglobin (27,28). Ultimately, the linkage analysis 
approach has been successfully used in combination with protein species containing only 
single interactions for both PFK and hemoglobin, and the two-state models of allostery 
were found to be inadequate to explain either of these systems (102,103,104). 
 Using the theory derived by Reinhart for the symmetrical dimer, which is most 
applicable to phosphorylase, the magnitude of the coupling between ligands can be 
established (101,105). This approach allows the determination of the nature and 
magnitude of the allosteric interactions between different ligands (heterotropic coupling) 
by the measurement of the dissociation constants for substrate via titration curves in the 
absence and the saturating presence of the allosteric effector. The coupling constant (Q) 
is defined as the ratio between the two. For phosphorylase; 
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where QAMPPi is the coupling quotient between AMP and phosphate, oPiK  is the 
dissociation constant for phosphate in the absence of AMP and ∞PiK  is the dissociation 
constant in the saturating presence of AMP.  
 Experimentally the value of Q can be determined by taking the ratios of the 
values of the dissociation constants at the limits of the other ligand (101). This, however, 
implies that the range of effect for the other ligand, AMP in this case, must be 
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Figure 1.4: Theoretical log-log plot of allosteric activation in phosphorylase b. 
Behavior predicted from equation 1.2. Initial and final affinity for substrate shown 
as asymptotes at high and low effector. Heterotropic effect is quantified by value 
of QAMPPi. Range of activation represents the concentration range over which a 
change in activator concentration will perturb the apparent affinity for substrate. 
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determined. Far more information can be gained by examining the relationship between 
the concentration of effector and the dissociation constant for substrate. As seen in 
Figure 1.4 the affinity for substrate is dependent on the concentration of effector present 
with the magnitude of the coupling defining the separation between the plateaus, and the 
range over which the change in substrate affinity changes is dependent on the affinity for 
effector and the homotropic cooperativity in its binding. The relationship between these 
is given for phosphorylase by: 
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where K1/2 is the measured dissociation constant for phosphate at some concentration of 
AMP, oAMPK  is the dissociation constant for the binding of the first equivalent of AMP in 
the absence of phosphate, QAMP is the homotropic coupling quotient for AMP binding in 
the absence of phosphate, and QAMP / Pi is the homotropic coupling quotient for AMP 
binding in the saturating presence of phosphate. 
 The homotropic coupling quotients describe the degree of homotropic 
cooperativity observed in binding of a given ligand. Experimentally, these values can be 
quantified by the relationship to the Hill number determined from titration curves for that 
ligand. This relationship is given for AMP in the absence of phosphate as, 
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where QAMP is the coupling quotient for AMP binding and nH is the Hill number for 
AMP binding, both in the absence of phosphate. Experimentally, the Hill numbers for 
AMP binding are determined over a wide range of phosphate concentrations and the 
average Hill number as phosphate goes to zero is used. Similarly, the coupling quotient 
for AMP in the saturating presence of phosphate can be determined, as well as the 
homotropic coupling quotients in phosphate binding.  
 The treatment of phosphorylase data with such a systematic approach allows for 
the determination of the magnitude of the couplings between the various sites. 
Perturbations on the system generated by alterations to the protein sequence can be tested 
to see explicitly which parameters have been perturbed. The essential assumption that 
must be made with the two-state system is that only one conformation is active, and 
resulting data generated can only be interpreted to be stabilizing the active or inactive 
state (27, 28, 105). The application of linkage analysis to phosphorylase will allow not 
only the characterization of the effects of AMP on the wild-type system, but also allow 
perturbations on the system introduced through mutagenesis to be explicitly identified. 
Rather than simply stating that the enzyme is more or less responsive to effector as has 
been done in the past (68,70,73,89), linkage analysis offers the chance to determine if the 
change has come from a perturbation of the binding affinity, disruption of the 
homotropic cooperativity in binding, or from a disruption of the communication between 
the AMP and phosphate sites. Each type of perturbation will have a distinct effect on the 
relationship between the effector and substrate affinity. Considering the theoretical data 
presented in Figure 1.4, a change in substrate affinity would move the plot up or down. A 
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change in effector affinity would move the plot left or right. Changing the homotropic 
cooperativity in effector binding would compress or extend the range over which 
activation takes place, and altering the heterotropic cooperativity will alter the distance 
between the plateaus of substrate affinity (101). 
 This detailed analysis provides a powerful tool to determine the roles of the 
structural elements in glycogen phosphorylase b in the activation by AMP, and provides 
the opportunity to examine in detail the various models of allostery that have been 
proposed for phosphorylase b. We have set out in this study to determine if the 
continuous models of allostery in glycogen phosphorylase are correct, and to test the 
roles of the N-terminus, the acidic patch, the 280’s loop, and α-helix 1 in AMP 
activation of phosphorylase b. 
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CHAPTER II 
EXPERIMENTAL TEST OF THE KINETIC MODELS OF 
PHOSPHORYLASE b ALLOSTERY 
 
BACKGROUND 
 The regulation of phosphorylase has been studied in detail for decades (1,13), 
however the regulatory mechanism in muscle glycogen phosphorylase is complex and 
still not well understood. Kinetic data from glycogen phosphorylase have traditionally 
been analyzed and explained using two-state models of allostery (13,63,70,). Depending 
on the research group and the type of experiment performed both the MWC and KNF 
models have been invoked (13,38). Both models can explain the global observations of 
allosteric systems, and can adequately predict the system’s response to a perturbation, 
but the MWC model has been more extensively utilized due to the reduced number of 
fitting parameters (13). With hemoglobin and phosphofructokinase, two systems in 
which the 2-state models have been extensively tested, neither of the 2-state models have 
adequately described the allosteric properties of these systems (102,103,104). In both 
cases, the allosteric communications between sites were found to be unique and 
separable from each other.  
 Similarly, the 2-state models do not accurately describe the kinetics of glycogen 
phosphorylase. Even with the wild-type enzyme, major modifications of the 2-state 
models are required to explain the kinetics of glycogen phosphorylase (106). The 
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minimal requirement to fit such data has been to allow nonproductive binding of 
substrate to the inactive state of the enzyme. As a result of these inconsistencies, there 
has been an effort to derive a model of glycogen phosphorylase that is independent of 
the 2-state models. Two separate groups have developed continuous models to explain 
the kinetics of glycogen phosphorylase (74,76,77). One of the models also takes into 
account the inhibition by high concentrations of AMP (76). What both of these models 
have in common is the prediction that the enzyme must have AMP bound to both 
allosteric sites and substrate bound to both active sites before turnover can occur. These 
predictions are somewhat understandable given the high degree of homotropic 
cooperativity seen in the binding of substrates and effector (1), but are in contradiction 
with previous work done with a solid-state hybrid phosphorylase species that only has a 
single functional active site on a hybrid enzyme covalently linked to a gel matrix (107).  
The binding of substrate to the inactive site of the gel bound hybrids cannot be 
completely ruled out because the mode of inactivation used was the substitution of the 
active site cofactor, meaning that though doubtful the kinetic models could be correct. 
 Similarly, phosphofructokinase (PFK) hybrids have been studied from two 
different species, one having a great deal of homotropic cooperativity in effector binding 
(Bacillus stearothermophilus PFK) and the other having a great deal of homotropic 
cooperativity in substrate binding (E. coli PFK) (103,108). Both of these systems 
retained activity when only a single active site and a single allosteric site were 
monitored. In light of the previous studies done with phosphorylase and other systems, it 
is curious that two models developed to explain phosphorylase kinetics would make the 
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prediction of needing two equivalents of effector to activate the enzyme. It remains 
possible that the apparent requirement for both allosteric sites to be filled is explained by 
the high degree of homotropic cooperativity in AMP binding. That is, under normal 
turnover conditions, phosphorylase b would always have two AMP equivalents bound. 
In the experiments described below this prediction is tested utilizing a hybrid strategy to 
create a phosphorylase dimer in solution that has only one functional allosteric site. 
While there are significant experimental difficulties with these hybrids, the data show 
that activity can be measured in the absence of AMP (albeit only at extreme 
concentrations of phosphate) and that a very small degree of activation is observed on 
the binding of a single equivalent of AMP to glycogen phosphorylase b. Conversely, 
glycogen phosphorylase a showed full activation upon binding of a single equivalent of 
AMP. 
  
MATERIALS AND METHODS 
Materials: Rabbit liver glycogen, potassium phosphate, β-glycerophosphate, and AMP 
were purchased from Sigma-Aldrich (St. Louis, MO). Glucose-6-phosphate 
dehydrogenase was obtained from Roche Applied Sciences (Indianapolis, IN). 
Phosphoglucomutase was from Sigma-Aldrich or Roche Applied Sciences. NADP was 
purchased from Research Products International Corporation (Mt. Prospect, IL) 
Restriction enzymes and T4 DNA ligase were obtained from New England Biolabs 
(Beverly, MA). Klenow fragment was from Promega (Madison, WI). All other 
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chemicals were from Sigma-Aldrich. Ion exchange chromatography resins were from G 
E Healthcare (Piscataway, NJ). Size exclusion resin was from Sigma-Aldrich. 
Molecular Biology: Site directed mutagenesis was carried out using a Quik Change Site 
Directed Mutagenesis Kit from Stratagene (La Jolla, CA). The charge tag mutants of 
glycogen phosphorylase, K596E and K596E/K792E, were created via site directed 
mutagenesis using the starting plasmid pTACTAC (65,109) and K596EpTACTAC, 
respectively. Similarly, the mutant R309E/R310E was created via a single round of site 
directed mutagenesis with either pTACTAC or K595E/K792EpTACTAC as the starting 
plasmids.  
 The plasmid pTACTAC∆BglII was created by using site directed mutagenesis to 
mutate the first of two BglII sites downstream of the glycogen phosphorylase gene in 
pTACTAC (109). The sequence was changed from the consensus site AGATCT to 
AGAACT to prevent cutting by BglII at this site.  
 The plasmid pTACTAC∆BglII∆GP was created by removal of the glycogen 
phosphorylase gene from pTACTAC∆BglII. This was accomplished by separate 
digestion of pTACTAC∆BglII and pALTER-Ex2 (Promega) with NdeI and HindIII. The 
products were separated by electrophoresis on a 1.5% agarose gel. The large band of the 
pTACTAC∆BglII digest and the small band of the pALTER-Ex2 (100 bp) digest were 
excised and the DNA purified using a Gel Extraction Kit from Qiagen (Valencia, CA). 
Approximately 30 ng of the pTACTAC∆BglII fragment was combined with a 3-fold 
molecular excess of the pALTER-Ex2 fragment and ligated together in a 20 µl total 
volume reaction by overnight incubation at room temperature with T4 DNA ligase and 
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ATP. The resultant plasmid was transformed into XL1-Blue (endA1 recA1 gyrA96 thi-1 
hsdR17 relA1 supE44 lac[F’ proA + B + lacIq Z∆M15 Tn10(Tetr)]) competent cells 
(110). The plasmid isolated from single colonies was verified for size and by comparison 
to parent plasmids after both were digested with NdeI and HindIII. 
 The plasmid pACYC184∆HindIII was created from pACYC184 (New England 
Biolabs) by removal of the singular HindIII site. Removal of this site was carried out by 
the digestion of the plasmid with HindIII. 17 µl of digested plasmid was mixed with 2 µl 
of 330 µM dNTPs and 1 µl of Klenow fragment. Reaction was run for 15 min at 25 °C 
followed by 20 min at 75 °C to kill all enzymes. DNA was purified by ethanol 
precipitation. Purified plasmid was then religated by overnight reaction with T4 DNA 
ligase and ATP in a 20 µl total volume reaction. Following ligation, plasmid was 
incubated with HindIII prior to transformation into XL1-Blue competent cells. Plasmid 
purified from single colonies was verified for correct size and the inability to be cut with 
HindIII. 
 The plasmid pAB1 was created via cloning from portions of 
pTACTAC∆BglII∆GP (expression site for glycogen phosphorylase and half of lacIq), 
pACYC184∆HindIII (p15A origin of replication and chloramphenicol resistance 
marker), and pJF118EH (one half of lacIq gene)(111). Briefly, pTACTAC∆BglII∆GP 
was digested with HpaI and BglII. pACYC184∆HindIII was digested with BamHI and 
AvaI, and pJF118EH was digested with AvaI and HpaI. Digestion products were 
separated by electrophoresis on a 1.5% agarose gel, and the 3.2 kb fragment of 
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pACYC184∆HindIII, the 1 kb fragment of pTACTAC∆BglII∆GP and the 0.76 kb 
fragment of pJF118EH were excised and purified following the protocol from a Gel 
Extraction Kit from Qiagen. Fragments were mixed in a 1:3:3 molecular ratio of 
pACYC184∆HindIII : pTACTAC∆BglII∆GP : pJF118EH using approximately 30 ng of 
the pACYC184 fragment. Plasmid was then ligated overnight at room temperature by 
addition of T4 DNA ligase and ATP in a 20 µl total volume reaction. The resulting 
plasmid was transformed into XL-1Blue competent cells, and plasmid isolated from 
single colonies was verified by size and digestion with Nde1 and Ava1.  
 The plasmid pAB1GP was created by the insertion of wild-type glycogen 
phosphorylase gene into pAB1 between the NdeI and HindIII sites. pAB1 and 
pTACTAC were digested with NdeI and HindIII separately and the products separated 
by electrophoresis on a 1.5% agarose gel. The large band from pAB1 and the smaller 
band of pTACTAC were excised, and the DNA was isolated using a Gel Extraction Kit. 
Approximately 30 ng of the pAB1 fragment was mixed with a 3-fold molecular excess 
of the pTACTAC fragment and ligated overnight at room temperature by addition of 
T4DNA ligase and ATP in a 20 µl total volume reaction. 
Protein Expression: The phosphorylase used in this study was from expression of 
rabbit muscle glycogen phosphorylase in Escherichia coli strain DF1020 (pro-82, 
glnV44(AS), ∆pfkB201, recA56, endA1, ∆(rhaD-pfkA)200, thi-1, hsdR17) (112,113) as 
previously described (65). Briefly, homodimeric wild-type or mutant enzymes were 
expressed from pTACTAC (65,109), and grown to saturation at 37 °C in a 40 mL 
overnight culture grown. Cells were diluted into 1.5 L LB and further growth was 
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carried out in the presence of 3 mM MnCl2, 0.5 mM pyridoxine, and 0.25 mM IPTG at 
27 °C for 48 hr as previously described (65). Cell pellets were typically frozen at -80 °C 
prior to use. 
 Hybrid dimers were formed in vivo by the co-expression of wild-type gene on 
pAB1GP and the gene coding for K596E/K792E/R309E/R310E on pTACTAC in 
DF1020 cells containing both plasmids. Co-expression required the use of both 
ampicillin and chloramphenicol in the growth media. Other growth conditions were 
identical to expression of homodimers. 
Protein Purification: Protein purification was carried out with modifications of 
previously described methods (65). Briefly, for wild-type, cell pellets from 1.5-3 L of 
culture were thawed and resuspended in 75 mL of resuspension buffer (50 mM β-
glycerophosphate (pH 7.0), 30 mM β-mercaptoethanol, 1 mM EDTA, 0.2 mM PMSF, 
0.7 µg/mL pepstatin A, 0.5 µg/mL leupeptin, 0.01% benzamidine). Cells were lysed by 
sonication until the OD600 was approximately 1/10th of the starting value. Debris was 
pelleted by centrifugation at 14,000 g for 45 min. The supernatant was brought to 0.5% 
polyethylenimine by addition of a 10% solution (40 mM β-glycerophosphate, 10% 
polyethylenimine), and stirred on ice for 30 min. The precipitate was removed by 
centrifugation at 14,000 g for 45 min. Solid (NH4)2SO4 was added to the supernatant to 
achieve 50% saturation, and stirred on ice for 20 min. The precipitated protein was 
recovered by centrifugation at 14,000 g for 30 min. The pellet was resuspended in 25 mL 
of column buffer (25 mM β-glycerophosphate (pH 7.0), 1 mM β-mercaptoethanol, 1 
mM EDTA, 0.2 mM PMSF, 0.01% benzamidine), and dialyzed against three changes of 
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the same buffer. The protein was then applied to DEAE-Sepharose fast flow and SP-
Sepharose Fast Flow columns run in tandem. Fractions from the load and wash showing 
activity were pooled and used for subsequent kinetic experiments. 
 For mutant enzymes, K596E/K792E and K596E/K792E/R309E/R310E, 
purification was as for wild-type except for the chromatography. A single DEAE column 
was used and the protein was eluted with a 0-250 mM KCl gradient in column buffer. 
Fractions showing activity were pooled for use in kinetic experiments. The purity of 
homodimeric enzymes was checked by 10% SDS-polyacrylamide gel electrophoresis. 
 For hybrid dimers, purification was carried out as for the mutant homodimers, 
except that 2 mM AMP was included in the column buffer. In addition, hybrid dimers 
were run over a second DEAE column immediately prior to kinetic experiments. The 
purity of the hybrid was checked using non-denaturing polyacrylamide gel 
electrophoresis. Protein was quantified using the Pierce (Rockford, IL) BCA Protein 
Assay.  
Kinetic Measurements: Kinetic measurements were carried out in the direction of 
glycogen degradation utilizing a coupled enzyme assay that linked the formation of the 
product glucose-1-phosphate to the formation of NADPH (Figure 2.1). Reaction assays 
were carried out in 600 µl total volume with 50 mM Pipes (pH 6.8), 0.1 mM EDTA, 5 
mg/mL glycogen, 0-10 mM AMP, 0.03-1000 mM potassium phosphate with 
compensating KCl added to match maximal phosphate concentration, 0.36 mM NADP, 
4 µM glucose-1,6-bisphosphate, 10 mM MgCl, 6.7 units/mL phosphoglucomutase, and 3 
units/mL glucose-6-phosphate dehydrogenase. The formation of NADPH was followed  
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(glc (α1,4) glc)n + PO4   (glc (α1,4) glc)n-1 + glucose-1-phosphate 
  
phosphorylase 
Phosphoglucomutase 
glucose-6-phosphate 
Glucose-6-phosphate 
Dehydrogenase 
NADP+ 
NADPH 
6-phosphoglucolactone 
A 
B 
Figure 2.1: Scheme for the coupling of the reaction of glycogen phosphorylase to the production of 
NADPH. A) Glycogen phosphorylase reaction in the direction of glycogen degradation. B) Enzymes 
coupling the degradation of glycogen to the production of NADPH which can be followed as and increase 
in absorbance at 340 nm. 
35 
 
at 340 nm in a Beckman 600 Series UV/Vis spectrophotometer. The temperature was 
maintained at 25±1 °C by a circulating water bath. Phosphate titrations were carried out 
at constant AMP concentration, and then repeated at varying AMP concentrations. 
Forphosphorylase a protein was preincubated overnight with 5 mg/mL glycogen prior to 
kinetic experiments and the phosphate concentration was limited to 0.03-100 mM with 
KCl added to correspond to the maximal phosphate concentration used. Data are 
reported as units of activity per milligram of phosphorylase, where 1 unit is equal to 1 
µmol glucose-1-phosphate formed per minute. 
Native Polyacrylamide Gel Electrophoresis: Polyacrylamide gels (7.5%) were made 
according to the instructions for the Laemmli SDS-PAGE for Mini Protein Cell from 
BioRad (Hercules, CA) with the exception that the SDS was left out of the gel and both 
the loading, and running buffers. Protein samples were mixed with loading buffer and 
loaded on to the gel without heating. Electrophoresis was performed for 2 hrs at 100 V 
on ice. 
Formation and Purification of Phosphorylase a: Phosphorylase a was made from 
purified phosphorylase b utilizing commercially available phosphorylase kinase and 
previously described methods (68). Hybrid phosphorylase a was formed by partially 
purifying phosphorylase via ammonium sulfate precipitation from cells co-expressing 
wild-type and the K596E/K792E/R309E/R310E mutant and incubating with 
phosphorylase kinase and ATP. Briefly, following resuspension of the ammonium 
sulfate pellet, the protein was dialyzed into two changes of column buffer followed by 
two changes of kinase buffer (50 mM Tris (pH 8), 10 mM MgCl2, and 6 mM NaF). 
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Phosphorylase kinase (6 mg) and 1 mM final concentration of ATP was added to the 
protein and allowed to react overnight. The protein was then loaded on a DEAE column 
at pH 7.3 and eluted with a 0-250 mM KCl gradient. Fractions with peak activity were 
pooled and concentrated. The protein was then loaded onto a G200 size exclusion 
column and the purist fractions were loaded onto a second DEAE column equilibrated at 
pH 7. The cleanest hybrid fractions as accessed by native polyacrylamide gel 
electrophoresis were selected and incubated overnight with 5 mg/mL glycogen prior to 
kinetic experiments.  
Kinetic Analysis: Initial velocity data in the direction of glycogen degradation were 
plotted as a function of phosphate concentration. Titration data were fit to a modified 
version of the Hill equation (114) that takes into account substrate inhibition:  
           (2.1) 
 
where vo is the initial velocity measured, Vmax is the maximal velocity, n is the Hill 
number, K1/2 is the apparent average (geometric mean) dissociation constant for 
phosphate, and Ki is the inhibition constant for phosphate. The K1/2 values were replotted 
as a function of AMP, and the resulting data were fit to  
 [ ]
[ ] 




+
+
= 2
2
2/1 AMPQK
AMPKKK
AMPPiAMP
AMP
pi  (2.2) 
where Kpi is the dissociation constant for phosphate in the absence of AMP, KAMP is the 
dissociation constant for AMP in the absence of phosphate, and QAMPPi is the 
heterotropic coupling quotient between AMP and phosphate. Equation 2.2 is a modified 
(K1/2n + [PO4]n) (1 + [PO4]/Ki) 
Vmax [PO4]n vo =
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version of the thermodynamic linkage equation derived in the absence of homotropic 
cooperativity in effector binding (101). The squaring of the effector concentration is an 
imperfect approximation for dealing with the strong homotropic cooperativity seen in 
AMP binding to glycogen phosphorylase b.  
 Data from phosphorylase a, which does not show homotropic cooperativity in 
AMP binding were fit to the original thermodynamic linkage equation in the absence of  
homotropic cooperativity in effector binding(101). 
 [ ][ ]



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+
+
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AMPQK
AMPKKK
AMPPiAMP
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Pi2/1  (2.3) 
 Phosphorylase mutants that did not show activation by AMP were fit to the 
competitive inhibition equation; 
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AMPKK 12/1  (2.4) 
where KiAMP  is the inhibition constant for AMP (19). 
 
RESULTS 
Wild-Type Phosphoryase Kinetics: Studies of glycogen phosphorylase typically 
follow the reverse reaction to avoid reported non-linear kinetics (68,70). For this study, 
we have followed the reaction in the physiological direction of glycogen degradation. 
Due to the high concentrations of phosphate required to measure activity at low AMP 
concentrations, KCl was added to match the highest concentration of potassium 
phosphate added. The titration curves showed an apparent substrate inhibition at high 
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phosphate concentrations, but this can be taken into account by fitting the data to 
equation 2.1 (Figure 2.2A). Previous studies have described wild-type glycogen 
phosphorylase b as being inactive in the absence of AMP (13). This observation is 
certainly true under physiological concentrations of phosphate, but at high 
concentrations of phosphate activity can be measured. The limited data generated at low 
AMP concentration make determining the Vmax difficult, but the data can be fit to 
equation 2.1 with the Vmax fixed to the value found at higher AMP concentrations. 
Replots of K1/2 as a function of AMP have been prepared to examine the degree of 
activation by AMP (Figure 2.3). The values of Hill numbers for phosphate binding at 
low AMP were well beyond the theoretical maximum (i.e. 2) for the dimeric system 
(data not shown). The finding that glycogen phosphorylase b can be active in the 
absence of AMP indicates that the proposed continuous kinetic models cannot be 
completely true over all concentrations. However, the modification to the models is 
minimal, and it is still relevant to ask if the activation by AMP requires two equivalents 
to be bound.  
 Unfortunately, the substrate inhibition observed in these experiments was shown 
to be an experimental artifact cause by an incorrect method of compensating for the salt 
effects of phosphate. While osmotic affects often dictate the properties of a solution 
(115), ionic strength, which takes into account the divalency of phosphate, dictates the 
affects on glycogen phosphorylase. When substrate titrations were carried out under 
conditions of equal ionic strength no substrate inhibition was observed, and the plots are 
biphasic indicating that phosphate may activate at high concentrations in a manner  
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Figure 2.2: Titrations curves of wild-type glycogen phosphorylase b. Initial velocity data are reported as units 
(µmol glc-1-P / min) of activity per milligram of phosphorylase. A) Phosphate diluted with KCl to match 
osmolarity. AMP was at 2.5 mM (•), 0.02 mM (◊) and 7.6X10-5 mM ( ). Lines represent best fit to equation 2.1. 
B) Phosphate titration at 0.78 mM AMP under conditions of equal ionic strength. Titrations were performed at 
25 °C with 5 mg/mL glycogen.  
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Figure 2.3: K1/2 vs. AMP for charge-tag and allosteric site 
phosphorylase b mutants. Replots of K1/2 vs. AMP are shown for 
wild-type (•), K596E/K792E ( ), and K596E / K792E / R309E / 
R310E (◊). K1/2 data are determined by fitting substrate titrations of 
phosphate at constant AMP to equation 2.1. Lines represent the best 
fit to equation 2.2 for wild-type and K596E/K792E or equation 2.4 
for K596E / K792E / R309E / R310E. Experiments were carried out 
at 25 °C with 5 mg/mL glycogen. 
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similar to sulfate (Figure 2.2B) (62). This result may explain the high Hill numbers 
observed in phosphate binding at low AMP. The salt effects on the titration curves make 
the measured values for the affinities for substrate and effector, as well as the 
quantification of the heterotropic coupling, meaningless. However, the dramatic changes 
that have been observed with the mutants and hybrids discussed herein show clearly 
different trends which are relevant to the question being addressed.  
Hybrid Strategy and Mutant Kinetics: Previous studies on hybrid glycogen 
phosphorylase involved fixing the enzyme to a solid matrix prior to dissociation and 
hybridization, and the activity of the enzyme was measured while it was still affixed to 
that matrix (107). For this study, a hybrid system was designed that allowed examination 
of the hybrid dimer in solution. The first challenge faced in developing our hybrid 
system was creating a mutant enzyme that does not bind to AMP and that can be 
separated and distinguished from wild-type phosphorylase. A charge-tag system, similar 
to what has been used with phosphofructokinase (103), was utilized to alter the 
chromatographic properties and allow separation via ion exchange chromatography 
while, at the same time, altering the electrophoretic mobility on a non-denaturing 
polyacrylamide gel. To this end, two surface residues of glycogen phosphorylase, which 
according to crystallographic structures do not appear to interact with other residues, 
were changed from lysine to glutamate. The phosphoryl binding pocket AMP binding 
site is made partially made up of arginine residues 309 and 310. To diminish the 
enzyme’s ability to bind AMP, residues 309 and 310 were changed to glutamate (13). 
The resultant mutants were combined to form the final K596E/K792E/R309E/R310E 
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used to make the hybrid dimers. The mutant K596E/K792E/R309E/R310E could be 
clearly distinguished from the wild-type homodimer on native-polyacrylamide gel 
electrophoresis (Figure 2.4, Lanes 1 and 2). 
 b Hybrid Formation: Despite reports on various methods to reversibly dissociate 
glycogen phosphorylase b (107,116,117), attempts to utilize heat, citrate, KSCN, and 
mercury benzoate all failed to form hybrid dimers. As such, another strategy had to be 
employed. Since co-expression of wild-type and mutant E. coli PFK was shown to be 
successful in formation of hybrids in that system (103,104), a similar strategy was 
applied here. In order to achieve co-expression, the expression strain had to be 
transformed with two plasmids; one expressing wild-type phosphorylase, and the other 
expressing a mutant enzyme. In order for two plasmids to be maintained in one cell they 
had to contain different origins of replication, and different selection markers (118). In 
addition, glycogen phosphorylase must be under an inducible promoter to avoid cell 
toxicity (65). The expression strain used here (DF1020) does not contain the lacIq gene. 
The requirements for the second expression plasmid for glycogen phosphorylase were an 
origin of replication other than colE1, a selection marker other than ampicillin 
resistance, a lac promoter driving expression of the glycogen phosphorylase gene, and 
the lacIq gene. No suitable plasmid could be located from commercial sources, so the 
plasmid pAB1GP was created utilizing the expression cassette from pTACTAC, the 
p15a origin and chloramphenicol resistance from pACYC184 and the lacIq gene from 
pJF118EH as described in the Material and Methods section. pAB1GP, being a lower  
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Figure 2.4: Native gel from phosphorylase b hybrid purification. Non-denaturing 
7.5% polyacrylamide gel showing the positions of the parent homodimers of wild-
type (lane 1), K596E/K792E/R309E/R310E (lane 2), and hybrid fractions (lanes 3-
10) eluted form DEAE-Fast Flow Sepharose column. Elution was performed by 
using a 0-250 mM KCl linear gradient. Gel was run on ice for 2 hr at 100 V.  
hybrid 
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copy number plasmid, was used to express wild-type phosphorylase during hybrid 
expression.  
 Cells with both plasmids pTACTAC with the gene for the K596E / K792E / 
R309E / R310E mutant and pAB1GP  were grown in media containing both ampicillin 
and chloramphenicol, and glycogen phosphorylase was purified normally until 
resuspension of the ammonium sulfate pellet. 2 mM AMP had to be included in the 
column buffer in order to stabilize the hybrid dimers. Three peaks of activity eluted from 
a DEAE-Fast Flow Sepharose column. The first peak eluted in the wash and was shown 
to be wild-type. On application of a 0-250 mM KCl gradient to the column, two 
additional peaks were eluted. The first proved to contain hybrid dimer and the second 
was the mutant parent (Figure 2.4). The hybrids could not be entirely separated from the 
mutant homo-dimer. Special care was taken to ensure that no wild-type dimer was 
present in protein used for kinetics. The hybrids proved to be stable for no more than 24 
hrs, and after 48 hr wild-type homodimers could be detected in native gels. As such, 
kinetic experiments were completed within 24 hrs of purifying hybrid dimers.  
a Hybrid Formation: Hybrids of phosphorylase a were formed via co-expression as 
with phosphorylase b. Conversion to phosphorylase a was carried out by 
phosphorylation during the course of the purification. Isolation of the a hybrid dimer 
proved to be far more challenging than that of phosphorylase b. Ultimately, the 
combination of a size exclusion chromatography column followed by two DEAE 
chromatography columns (run at slightly different pH values) provided good separation 
and relatively pure hybrid dimers. (Figure 2.5) 
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Figure 2.5: Native gel from phosphorylase a hybrid purification. Non-denaturing 7.5% 
polyacrylamide gel showing the positions of the parent homodimers of wild-type (lane 
1), K596E/K792E/R309E/R310E (lane 2), and hybrid fractions (lanes 3-10) eluted 
form DEAE-Fast Flow Sepharose column. Elution was performed by using 0-250 mM 
KCl linear gradient. Gel was run on ice for 2 hr at 100 V.  
hybrid 
46 
 
Kinetics: The charge-tag mutant K596E/K792E was tested to verify that the 
introduction of these mutations had not significantly altered the kinetics of the enzyme. 
As can be seen in Figure 2.3, the affinities for phosphate and the response to AMP is 
nearly identical to wild-type. This was repeated for the phosphorylase a form of both  
wild-type and the K596E/K792E mutant. As can be seen in Figure 2.6 there is no 
significant effect of the modifications on the observed kinetic values.  
 The mutations R309E and R310E were added to selectively knock out binding of 
AMP to the allosteric site. Inhibition at high AMP is still expected as binding to the 
purine inhibition site should not be affected. This mutant was tested in both the a and b 
forms. The b form binds phosphate with slightly higher affinity than wild-type at low 
AMP, but there is no evidence of activation AMP. (Figure 2.3) As expected at high 
AMP concentrations the curve trends up presumably due to binding at the purine 
inhibition site. The a form of the mutant binds phosphate with lower affinity than wild-
type, but there is no observable activation by AMP (Figure 2.6). 
 The phosphorylase b hybrid dimer bound phosphate at low concentrations of 
AMP somewhat more weakly than either wild-type or the parent mutant. (Figure 2.7) 
Unlike the parent mutant the hybrid dimer shows some activation by AMP. This 
activation is much weaker than that of wild-type, but it is evident from the replot of K1/2 
that some activation is realized.  
 Contrary to what was observed with the phosphorylase b hybrid, the 
phosphorylase a hybrid bound phosphate more tightly than either wild-type or the parent  
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Figure 2.6: K1/2 vs. AMP for charge tag and allosteric site 
phosphorylase a mutants. Replots of K1/2 vs. AMP are shown for 
wild-type (•), K596E/K792E ( ), and K596E / K792E / R309E / 
R310E (◊). K1/2 data were determined from fitting of individual 
phosphate titration curves at constant AMP to the Michaelis-
Menton equation. Lines are represent the best fit to equation 2.3 
for wild-type and K596E/K792E or equation 2.4 for K596E / 
K792E / R309E / R310E. Experiments were carried out at 25 °C 
with 5 mg/mL glycogen. 
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Figure 2.7: Hybrid phosphorylase b K1/2 vs. AMP. Replot of 
K1/2 for phosphate as a function of AMP are shown for wild-
type (•), K596E/K792E/R309E/R310E (◊), and the hybrid 
dimer ( ). K1/2 data were determined by fitting individual 
phosphate titration at constant AMP to equation 2.1. Lines are 
best fit to equation 2.2 for wild-type and hybrid or equation 2.4 
for K596E/K792E/R309E/R310E. Experiments carried out at 
25 °C with 5 mg/mL glycogen. 
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mutant. (Figure 2.8) The degree of activation by AMP is very similar to that found with 
wild-type. 
 The maximal activity of the b hybrid dimer falls between that of wild-type and 
the K596E/K792E/R309E/R310E mutant, but it falls short of the mean between them 
(Table 2.1). The maximal activity of the a form of the hybrid falls well below that of  
either parent mutant for unknown reasons. The difference between the maximal 
activities between a form and b form is due to two factors. First, phosphorylation 
increases the maximal activity of glycogen phosphorylase (Chapter IV). Second, the 
maximal salt concentration utilized in measuring kinetics of b form was nearly 10-fold 
higher than that used with the a form, and there were significant salt effects observed. 
 
DISCUSSION 
 Most phosphorylase data have been understood with the generally accepted 
premise that there is an absolute requirement for AMP for the activity of phosphorylase 
b (13,68). Physiologically, where phosphate concentrations are less than 10 mM (19), 
this is certainly true, but the results with wild-type phosphorylase b shown here 
demonstrate that turnover does occur in the absence of AMP (Figure 2.1 and 2.2). Little 
data have been generated with phosphorylase at high substrate concentrations, probably 
due to a general assumption that Vmax is increased by AMP as well as the effect on K1/2 
for substrate (1). In this study, there is no evidence of an affect of AMP on Vmax 
(Chapter III). There are, however, dramatic effects on the affinity for phosphate. 
Technically, neither of the proposed continuous kinetic models of AMP activation can  
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Figure 2.8: Hybrid phosphorylase a K1/2 vs. AMP. Replot of K1/2 
for phosphate as a function of AMP are shown for wild-type (•), 
K596E/K792E/R309E/R310E (◊), and the hybrid ( ). K1/2 data 
were determined from fitting of individual phosphate titration 
curves at constant AMP to the Michaelis-Menton equation. Lines 
represent the best fit to equation 2.3 for wild-type and hybrid or 
equation 2.4 for K596E/K792E/R309E/R310E. Experiments 
carried out at 25 °C with 5 mg/mL glycogen. 
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 b Forma a Formb 
Enzyme Vmax (U/mg) Vmax (U/mg) 
Wild-type 7.1±0.2 29.8±0.3 
K596E/K792E/ 
R309E/R310E 1.47±0.04 28±1 
Hybrid dimer 2.8±0.1 11.8±0.24 
a Determined with salt concentration equal to 1 M potassium phosphate.  
b Determined with salt concentration equal to 100 mM potassium phosphate 
Table 2.1: Vmax for phosphorylase a and b variants 
used for hybrids. 
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be correct because they both require the binding of AMP prior to any activity (74,76,77). 
However, given the relevant concentrations under which phosphorylase is active, the 
addition of turnover in the absence of AMP is a rather minimal alteration. The data 
collected and used to establish the continuous kinetic models of phosphorylase activation 
would not be significantly affected by this additional branch (76). Likewise, the finding 
that a b hybrid dimer is activated to a slight degree by AMP must technically mean that 
the model is not correct with respect to activation by AMP (Figure 2.6). However, the 
activation is so slight that it would be indistinguishable in the wild-type data used to 
develop the models (76). The observations made here provide rather dramatic evidence 
that with respect to wild-type phosphorylase b the continuous kinetic models proposed 
are essentially correct. Only under extreme conditions would phosphorylase be induced 
to deviate from the models of activation as proposed. It must also be noted that both the 
models being investigated and the data presented here rule out both of the 2-state models 
as an accurate description of the kinetics of glycogen phosphorylase b. 
 It is interesting to note that the activation by AMP in the b hybrid is similar in 
extent to that observed with phosphorylase a (approximately a 25% decrease in K1/2 for 
phosphate). It may be that the mechanism preserved in the b hybrid dimer is the same 
mechanism by which phosphorylase a is activated by AMP.  
Given that phosphorylase is a dimeric enzyme and that the mutant forms used in 
this study have altered maximal activity from wild-type, the maximal activity of a hybrid 
would be expected to be the mean of the activities of the two parent enzymes as long as 
both the active sites maintain full function in the hybrid. It must be acknowledged that 
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the maximal activity of the hybrid dimers do not match the theoretically predicted 
values. The b form of the hybrid has an activity that falls between that of the parent 
homodimers, but it falls short of the mean. (Table 2.1) This may be in part due to the 
difficulty in accurately measuring the maximal activity in the face of the apparent 
substrate inhibition. Of far greater concern is the activity of the a hybrid form. The 
activity of this hybrid falls below that of either parent. (Table 2.1) The Michaelis-
Menten type kinetics of phosphorylase a allow for a better determination of maximal 
activity, and the activity observed falls to less than half that of the parent mutants. The 
low activity suggests a problem with the structure of the hybrid or indicates that only a 
single active site was functional. The cause of this anomaly is unknown. The activation 
of phosphorylase a being completely preserved in the hybrid is perhaps an indication 
that it is an intrasubunit effect rather than an intersubunit effect. 
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CHAPTER III 
THE N-TERMINUS OF GLYCOGEN PHOSPHORYLASE b IS NOT 
REQUIRED FOR ACTIVATION BY AMP 
 
BACKGROUND 
 Glycogen phosphorylase was the first enzymes recognized as being allosterically 
regulated, as well as the first case of regulation by phosphorylation (8,52,63). The 
allosteric regulation of glycogen phosphorylase was one of the early examples used in 
deriving the traditional 2-state models of allostery (27), despite the later realization that 
the 2-state models do not truly explain the kinetics of glycogen phosphorylase as 
discussed in Chapter II. The activating phosphorylation of phosphorylase b takes place at 
serine 14 and converts the enzyme to the more active phosphorylase a. 
 Recognition that muscle phosphorylase was activated by phosphorylation at 
serine 14, led to much early interest in the role of the N-terminus in the activation of 
phosphorylase (31, 43). The work done to establish the role of the N-terminus was 
published in 1968 and utilized phosphorylase b’, a form of the enzyme that had the first 
16 residues removed via proteolysis (31). The reported results stated that all of the 
allostery in phosphorylase was lost in the absence of the N-terminus. Specifically, it was 
found that AMP did not affect the affinity for phosphate and phosphate did not affect the 
affinity for AMP. In addition, there was no homotropic cooperativity in the binding of 
substrate or effectors observed with phosphorylase b’. These findings led to the 
conclusion that the N-terminus was responsible for transmitting the allosteric signal in 
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phosphorylase b. As the age of structural biology was born, the conclusions drawn from 
phosphorylase b’ were and have remained the basis for interpreting the crystallographic 
structures of glycogen phosphorylase (63,68,83). It must be noted, however, that 
phosphorylase b’ was derived by limited proteolysis of enzyme purified from rabbit 
muscle, and that there were additional effects of proteolysis on the primary structure of 
the enzyme. Given that modern experimental techniques, particularly in molecular 
biology and data analysis, have advanced the ability to specifically address the role of 
the N-terminus of glycogen phosphorylase, we have undertaken this study to evaluate 
the significance of the N-terminus of glycogen phosphorylase b in activation by AMP. 
We report here, for the first time, the full magnitude of the effect of AMP on glycogen 
phosphorylase b. We also show that the N-terminal truncate lacking the first 17 residues, 
∆2-17, of rabbit muscle glycogen phosphorylase retains all of the heterotropic and 
homotropic cooperativity observed in wild-type phosphorylase, but ∆2-17 has a reduced 
affinity for both AMP and phosphate. In addition, we were able to apply the same 
experimental design to the proteolytically derived phosphorylase b’. These data and 
experimental techniques are compared to the original findings with phosphorylase b’.  
 The use of constant ionic strength in these experiments allows the quantification 
of the kinetic constants for glycogen phosphorylase without ambiguity. Unlike the data 
reported in Chapter II, the data reported here are not obscured by salt effects from the 
addition of phosphate, and reflect the properties of the enzyme under the experimental 
conditions. 
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MATERIALS AND METHODS 
 The phosphorylase used in this study was obtained from bacterial expression of 
the recombinant rabbit muscle glycogen phosphorylase gene in the plasmid pTACTAC 
obtained from Robert J. Fletterick as previously described (65). Purified phosphorylase 
was stored at 4 ºC and generally used within one week. β-glycerophosphate was from 
Sigma-Aldrich (St. Louis, MO) or USB (Cleveland, OH). Restriction enzymes were 
from New England Biolabs (Beverly, MA). Ion exchange chromatography resins were 
from Amersham Biosciences (Piscataway, NJ). Size exclusion resin, glycogen 
phosphorylase kinase, trypsin, and soybean trypsin inhibitor were from Sigma-Aldrich. 
Glucose-6-phosphate dehydrogenase was from Roche Applied Sciences (Indianapolis, 
IN). Phosphoglucomutase was from Roche Applied Sciences or Sigma-Aldrich. Other 
chemicals were from Sigma-Aldrich. 
Mutagenesis/Molecular Biology: The plasmid pTACTAC with the gene for wild-type 
glycogen phosphorylase gene from rabbit muscle inserted between NdeI and HindIII 
sites as previously described was used as the starting template for mutagenesis (65). The 
truncate ∆2-17 was created by using Quik Change Site Directed Mutagenesis Kit 
(Stratagene, La Jolla, CA) to introduce a second NdeI cut site positioning the starting 
ATG at codon 17. The resulting plasmid was digested to completion with NdeI and gel 
purified to remove the DNA sequence between codons 1 and 17. The plasmid was then 
re-ligated to obtain the plasmid with a phosphorylase gene missing the DNA residues 
coding for amino acids 2 through 17.  
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Protein Expression and Purification: Wild-type and mutant phosphorylase were 
expressed from plasmid pTACTAC as previously described (65) with the exception that 
the growth was carried out in E. coli strain DF1020 (pro-82, glnV44(AS), ∆pfkB201, 
recA56, endA1, ∆(rhaD-pfkA)200, thi-1, hsdR17) (112, 113) for 48 hr at 27 ºC in 1.5 L 
cultures that were inoculated with 40 mL of culture grown to saturation at 37 ºC in the 
absence of inducer. Cell pellets from expression were stored at -80 ºC prior to protein 
purification. Protein purification was carried out with modifications of previously 
described methods (65). Briefly, wild-type cell pellets from 1.5-3 L of culture were 
thawed and resuspended in 75 mL of resuspension buffer (50 mM β-glycerophosphate 
(pH 7.0), 30 mM β-mercaptoethanol, 1 mM EDTA, 0.2 mM PMSF, 0.7 µg/mL Pepstatin 
A, 0.5µg/mL Leupeptin, 0.01% Benzamidine). Cells were lysed by sonication until the 
OD600 was approximately 1/10th of the starting value. Debris were pelleted by 
centrifugation at 14,000 g for 45 min. The supernatant was brought to 0.5% 
polyethylenimine by addition of a 10% solution (40 mM β-glycerophosphate, 10% 
polyethylenimine) and stirred on ice for 30 min. The precipitate was removed by 
centrifugation at 14,000 g for 45 min. Solid (NH4)2SO4 was added to the supernatant to 
50% saturation, and stirred on ice for 20 min. The precipitated protein was recovered by 
centrifugation at 14,000 g for 30 min. The pellet was resuspended in 25 mL of column 
buffer (25 mM β-glycerophosphate (pH 7.0), 1 mM β-mercaptoethanol, 1 mM EDTA, 
0.2 mM PMSF, 0.01% Benzamidine), and dialyzed against three changes of the same 
buffer. Protein was then run over DEAE-Sepharose Fast Flow and SP-Sepharose Fast 
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Flow columns run in tandem. Fractions from load and wash showing activity were 
pooled and used for subsequent kinetic and fluorescence experiments.  
For ∆2-17, purification was the same as above until the chromatography. ∆2-17 
was loaded on a Q-Sepharose Fast Flow column and eluted with a 0-300 mM KCl 
gradient in column buffer. The cleanest fractions (as assessed by 10% SDS-
polyacrylamide gel electrophoresis) with activity were pooled, dialyzed to remove salt, 
and loaded on a DEAE-Sepharose Fast Flow column. Elution was done with a 0-300mM 
KCl gradient in column buffer. The cleanest fractions with activity were pooled and 
dialyzed to remove salt prior to use in kinetic and fluorescence studies. Protein was 
quantified using Pierce (Rockford, IL) BCA protein assay. 
Phosphorylase a and Phosphorylase b’: Phosphorylase a was synthesized and isolated 
utilizing purified phosphorylase b and commercially available phosphorylase kinase as 
previously described (70). Phosphorylase b’ was made using phosphorylase a following 
the protocol of Graves (31). 
Kinetic Measurements: Glycogen phosphorylase activity was followed in the direction 
of glycogen degradation at 25 ºC utilizing phosphoglucomutase and glucose-6-phosphate 
dehydrogenase in a coupled enzyme assay system to link the degradation of glycogen to 
the production of reduced NADPH, which was followed at 340 nm on a Beckman 600 
series UV/VIS spectrophotometer. Assays were carried out in a 600 µL reaction volume 
containing 50 mM PIPES (pH6.8), 100 µM EDTA, 5 mg/mL rabbit liver glycogen, 0-5 
mM AMP, 0-300 mM potassium phosphate, 360 µM NADP, 4 µM glucose-1,6-
bisphosphate, 10 mM MgCl2, 6.7 U/mL phosphoglucomutase, 3 U/mL glucose-6-
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phosphate dehydrogenase. Changes in ionic strength due to varying phosphate 
concentrations were compensated for by the addition of appropriate amounts of KCl. 
Temperature was maintained within 1 ºC by a circulating water bath. The assay mixes 
were preincubated at 25 ºC, and the reaction was initiated by addition of appropriately 
diluted glycogen phosphorylase. 
Steady State Fluorescence: Spectral measurements were collected on an SLM-4800 
instrument with a Phoenix upgrade package from ISS (Champaign, IL). Spectra were 
collected with a 295 nm excitation wavelength at 25 ºC in a 1 cm by 1 cm cuvette. 
Excitation slits were set to 2 nm, and emission slits were set to 8 nm. All measurements 
were collected with protein in column buffer. The same buffer without protein was used 
as a blank to correct spectra. For experiments with AMP, 2 mM AMP was added to the 
blank as well as the sample. 
Data Analysis: Initial velocity data were plotted as titrations for both phosphate and 
AMP and individual titration curves fit to the Hill equation to determine K1/2 and Hill 
number (114). Replots of Hill number for AMP vs. phosphate were used to establish the 
homotropic coupling between AMP sites at low phosphate concentration per equation 
3.1 (101).  
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where AMPQ  is the homotropic coupling quotient in AMP binding in the absence of 
phosphate. Hn  is the Hill number for AMP binding in the absence of phosphate. 
Analogous approaches were used to quantify the homotropic coupling quotient for AMP 
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binding in the saturating presence of phosphate, as well as the homotropic coupling 
quotient for phosphate binding in the absence and saturating presence of AMP. 
Quantification of the heterotropic coupling between AMP and phosphate was 
carried out with replots of K1/2 for phosphate as a function of AMP utilizing the 
thermodynamic linkage approach of Reinhart (equation 3.2) with the values for 
homotropic coupling quotients for AMP binding fixed to the values established by the 
replots of Hill number (101).  
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where oPiK  is the dissociation constant for phosphate in the absence of AMP. 
o
AMPK is the 
dissociation constant for the first equivalent AMP in the absence of phosphate. AMPQ  is 
the homotropic coupling for AMP binding in the absence of phosphate. PiAMPQ /  is the 
homotropic coupling for AMP binding in the saturating presence of phosphate. AMPPiQ  is 
the heterotropic coupling quotient between AMP and phosphate.  
 The measured coupling quotients were converted to the free energy of coupling 
by the relationship between free energy and the coupling quotient given in equation 3.3. 
 QRTGcoupling ln−=∆  (3.3) 
where couplingG∆  is the free energy of coupling, R is the gas constant, T is the 
temperature, and Q is the coupling quotient of interest. 
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Activity Gels: Equal units of activity for WT and ∆2-17 glycogen phosphorylase b were 
applied to 7.5% non-denaturing polyacrylamide gel, and electrophoresis was carried out 
at 100 V for 2 hr on ice. As previously described, gels were in incubated with 1% 
glycogen, 20 mM glucose-1-phosphate, 10 mM AMP in 50 mM PIPES buffer (pH 6.8) 
for AMP activation, or 1% glycogen 30 mM glucose-1-phosphate, 0.6M(NH4)2 SO4 in 
50 mM PIPES (pH 6.8) for sulfate activation (3). Incubation was carried out for 4 hr at 
room temperature. Following incubation gels were stained with a saturated solution of I2 
and photographed. 
 
RESULTS  
Wild-type Phosphorylase b Expression and Kinetics: Glycogen phosphorylase when 
expressed in E. coli is isolated as pure b form due to the lack of phosphorylase kinase. 
Wild-type phosphorylase b was successfully expressed in E. coli DF1020 and gave 
similar yields to those previously reported (65). Titrations were carried out from 0 to 330 
mM phosphate and 0-5 mM AMP under constant ionic strength. There is little to no 
effect on Vmax for the enzyme upon addition of AMP while there is a dramatic effect on 
the affinity for phosphate. The replots of Hill number vs. phosphate or AMP allow the 
quantification of the homotropic cooperativity (Figure 3.1 and Table 3.1). Once the 
values for homotropic effects in AMP binding are established the replot of K1/2 for 
phosphate vs. AMP can be fit to equation 3.2 and the coupling between AMP and 
phosphate can be quantified (Figure 3.2 and Table 3.1). This experimental approach 
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Figure 3.1: Replots of Hill number vs. the other ligand for wild-type and N-terminal truncates. (A) Replot 
of Hill number for phosphate vs. AMP. (B) Replot of Hill number for AMP vs. phosphate. Wild-type is 
shown as filled circles (•). ∆2-17 is shown as open circles (o). Phosphorylase b’ is shown as open squares 
( ). 
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Figure 3.2: Replot of K1/2 for phosphate as a function of 
AMP for wild-type and N-terminal truncates. Wild-type 
(•), ∆2-17 (o), and Phosphorylase b’ ( ) are shown with 
standard errors. K1/2 data were determined from phosphate 
titrations fit with the Hill equation. Lines represent the best 
fit to equation 3.2 with values for homotropic coupling 
quotients for AMP fixed to the values determined from the 
Hill numbers observed in AMP titrations at high and low 
phosphate. All experiments were carried out with constant 
ionic strength at 25° C and with 5 mg/mL glycogen 
present. 
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 aDissociation constants and heterotropic coupling free energy determined from replots of K1/2 for phosphate as 
a function of AMP. b∆GPi-AMP is coupling free energy between AMP and phosphate, which is calculated from 
the heterotropic coupling quotient. c∆GPi and ∆GPi/AMP are homotropic couplings in absence and saturating 
presence of AMP respectively. d∆GAMP and ∆GAMP/Pi are homotropic coupling free energy for AMP in absence 
and saturating presence of phosphate respectively. Homotropic free energies calculated from Hill numbers in 
absence and saturating presence of other ligand.   
Table 3.1: Kinetic constants and coupling free energies for wild-type 
(WT b), ∆2-17, and phosphorylase b’ (b’).  
 WT b ∆2-17 b' 
KPio (mM)a 259±3 848±29 129±10 
KAMPo (mM)a 0.43±0.01 5.8±0.4 0.033±0.005 
∆GPi-AMP (kJ/mol)b -7.5±0.4 -10±2 -6±1 
∆GPi (kJ/mol)c -15± 4 -11±2 0.0 
∆GPi/AMP (kJ/mol)c -1.4± 0.2 -0.2±0.1 0.0 
∆GAMP (kJ/mol)d -5.9± 4 -11.5±0.6 4.6±0.8 
∆GAMP/Pi (kJ/mol)d -0.9± 0.4 -7±2 -0.39±0.07 
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allows the measurement of activity in the absence of AMP allowing the complete 
quantification of the coupling between AMP and phosphate.  
∆2-17 Expression and Kinetics: DNA manipulation of the gene for rabbit muscle 
glycogen phosphorylase allows for the creation of a mutant protein that lacks the N-
terminus (∆2-17). The mutant protein was successfully created, expressed, and purified. 
When the kinetics of the ∆2-17 mutant are measured, it displays a reduced affinity for 
AMP and phosphate as can be observed by the curve being shifted up and to the right in 
Figure 3.2 (also Table 3.1). A clear dependence of the affinity for phosphate on the 
presence of AMP is observed, and conversely there is a clear dependence of the affinity 
for AMP on the presence of phosphate (Figures 3.2 and 3.3). Comparing the free 
energies of coupling in Table 3.1, it can be seen that there is slightly more cooperativity 
observed between AMP and phosphate binding with the ∆2-17 mutant compared to 
wild-type. The absence of the N-terminus clearly did not alleviate the heterotropic 
cooperativity in phosphorylase. The ∆2-17 enzyme also retains homotropic cooperativity 
with respect to both AMP and phosphate as reported in Table 3.1. To rule out the 
possibility of significantly altered secondary or tertiary structure in the ∆2-17 mutant, the 
intrinsic tryptophan fluorescence emission spectrum was recorded with excitation at 295 
nm. The spectrum of ∆2-17 matched the spectra of wild-type for both apo and with 2 
mM AMP (data not shown).  To test the ability of sulfate to activate ∆2-17, 
electrophoresis was carried out with wild type and ∆2-17 on 7.5% non-denaturing 
polyacrylamide gels. After reaction in the direction of glycogen synthesis by incubation  
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Figure 3.3: Line plot of K1/2 for AMP as a function of phosphate 
for wild-type and N-terminal truncates. Wild-type (•), ∆2-17 (o), 
and Phosphorylase b’ ( ) are shown with standard errors. Data 
generated with constant ionic strength at 25°C with 5 mg/mL 
glycogen. 
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with glycogen and glucose-1-phosphate the gels were stained with iodine. Although 
AMP activates both wild-type and ∆2-17, ∆2-17 is not activated by sulfate (Figure 3.4).  
Phosphorylase b’: To assess the differences between our findings with ∆2-17 and the 
originally published results in the absence of the N-terminus, we created phosphorylase 
b’ from wild-type phosphorylase a according to the original protocols (31). As 
previously reported, phosphorylase b’ had a higher affinity for phosphate and AMP 
(Figure 3.2 and Table 3.1). However, there is still a great dependence of the affinity for 
phosphate on the presence of AMP. Interestingly, the slope of the transition region is 
much reduced with respect to both wild-type and ∆2-17. In agreement with the previous 
work (31), there is no evidence for cooperativity in binding of phosphate at any 
concentration of AMP. At low phosphate concentrations, the Hill number for AMP is 
approximately 0.56±0.03 indicating significant negative homotropic cooperativity in 
AMP binding. (Figure 3.1B) The Hill number returns to unity at higher concentrations of 
phosphate, indicating that this is a real case of negative homotropic cooperativity.  
 
DISCUSSION 
 Wild-Type Phosphorylase: Previously, phosphorylase b has been held to be inactive 
without AMP present (13,52,63), but under the experimental conditions used in this 
study, activity can be measured and affinity for phosphate can be determined even in the 
absence of AMP. These data, when analyzed with linkage analysis rather than simply 
using a model that assumes an equilibrium between active and inactive forms of the  
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Figure 3.4: Activity gels with wild-type and ∆2-17 glycogen 
phosphorylase b. Activity shown by 4hr incubation of equal units 
of wild-type and ∆2-17 in (A) 1% glycogen, 20 mM glc-1-
phosphate, 10 mM AMP or  (B) 1% glycogen, 20 mM glc-1-
phosphate, and 1 M (NH4)2SO4. Stain developed by incubation with 
iodine.  
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enzyme, allow the complete quantification of the allostery in glycogen phosphorylase b 
with respect to AMP and phosphate. Many previous reports have shown the activation 
by AMP, but none have quantified the extent of coupling (13,31,67). This report 
provides a complete analysis of the extent of heterotropic coupling between phosphate 
and AMP in glycogen phosphorylase b. 
∆2-17 and Phosphorylase b’: The results with the truncate ∆2-17 are in clear 
disagreement with the previously reported loss of cooperativity in phosphorylase b’ (31).  
Loss of affinity for both substrate and effector is evident, but there is no loss in 
heterotropic coupling. (Figure 3.2) In contrast, it is clear that substantial homotropic 
cooperativity with both AMP and phosphate has been retained in the absence of the N-
terminus. In light of these findings, the current proposal that the N-terminus transmits 
the allosteric signal across the subunit interface becomes highly improbable. The 
possibility that these differences are due to the trivial cause of different experimental 
conditions has been ruled out by examination of phosphorylase b’. When phosphorylase 
b’ was tested under the same conditions as ∆2-17, results similar to those originally 
reported were found, confirming that there are different heterotropic and homotropic 
cooperativities in ∆2-17 and phosphorylase b’. The likely source of these differences is 
the use of proteolysis to generate phosphorylase b’. It has been reported previously (31) 
that phosphorylase is cleaved multiple times under the conditions used to remove the N-
terminus. These additional cleavages were assumed to be inconsequential. However, the 
findings that ∆2-17, which is of known primary structure, retains both homotropic and 
heterotropic cooperativity indicate that the additional cleavage sites in phosphorylase b’ 
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have dramatic effects. Irrespective of these differences, examining phosphorylase b’ 
over a much larger concentration range of AMP shows that there is a great deal of 
heterotropic activation retained.  The two variants lacking the N-terminus both show that 
allosteric activation by AMP is present in the absence of the N-terminus, though it is 
much reduced with phosphorylase b’ (Figure 3.2), leading to the conclusion that the N-
terminus is not required for the activation by AMP.  
 The N-terminus being located at the subunit interface may be an artifact of the 
crystallization method rather than the mechanism by which the allosteric signal is 
transmitted. It appears that the N-terminus probably does have a role in establishing the 
binding characteristics of phosphorylase, since the affinities for phosphate and AMP are 
greatly altered in its absence. However that role is independent of any role in the 
allosteric coupling in the enzyme, which is not greatly disturbed. Also of interest, the N-
terminus is clearly implicated in activation by phosphorylation and by high 
concentrations of sulfate (61,62). It has been a long standing theory that the activation of 
phosphorylase proceeds via the same mechanism irregardless of what the activation 
input is (13,52). Of course, phosphorylase cannot be activated by phosphorylation in the 
absence of the N-terminus, but activation by sulfate is also dependent on the N-terminus 
(Figure 3.4) (62). Previous structural studies have shown that the activation by sulfate 
proceeds via an interaction with both the N-terminus and the phosphoserine recognition 
site (62). The lack of activation by sulfate in the absence of the N-terminus (Figure 3.4) 
provides a strong indication that the mechanism of activation with phosphorylation may 
in fact be distinct from the activation by AMP.  
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Conclusions: Our understanding of the activation of glycogen phosphorylase has all 
been based on research looking at very narrow concentration ranges of substrates and 
AMP, and with a proteolytically derived enzyme of unknown primary structure (31). 
The new findings reported here indicate that the proteolysis dramatically altered the 
properties of phosphorylase in ways unrelated to the N-terminus and the broader 
concentration ranges used here have unmasked the effects of AMP in the absence of the 
N-terminus. The structural interpretations of the activation of glycogen phosphorylase 
should be reevaluated in the light of these new findings.  
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CHAPTER IV 
THE ROLE OF THE ACIDIC PATCH OF GLYCOGEN 
PHOSPHORYLASE b BY AMP 
 
BACKGROUND 
  Glycogen phosphorylase was the first enzyme to be characterized as an allosteric 
enzyme as well as the first enzyme to be shown to be regulated by phosphorylation (8). 
Physiologically, phosphorylase is activated by either phosphorylation of serine 14 or the 
noncovalent binding of AMP (8). In vitro, phosphorylase can also be activated by sulfate 
and polyamines (30,61). There are numerous crystallographic structures of glycogen 
phosphorylase in both the more active phosphorylated form (phosphorylase a) and the 
less active unphosphorylated form (phosphorylase b) as well as in numerous ligation 
states with both activators and inhibitors bound (for reviews see ref 8 and 13).  
Much of our understanding of phosphorylase regulation hinges on the 
interpretations of crystallographic data. The N-terminus (residues 1-22) is located at the 
acidic patch (residues 96, 105, 109, 110, 120, 501, 493, 505, 509) on its own subunit in 
some, but not all, reported inactive conformations, and the N-terminus is found at the 
subunit interface in some reported active structures (71). It has long been thought that 
this movement is a key mechanism of activation that brought about the tertiary and 
quaternary changes that lead to activation (13). The location of the phosphoserine 
recognition site at the subunit interface, being partially made up of arginines 43 and 69 
of the opposite subunit, has been well established structurally as well as confirmed 
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kinetically (13,89). The issue is far more complicated with respect to activation by AMP. 
The current proposal is that the activation of phosphorylase utilizes the same global 
mechanism of activation whether activated by AMP or phosphorylation, though some 
small local differences have been recognized (8,13). The first key piece of evidence that 
supports the proposal of a single activation mechanism was the failure of phosphorylase 
b’ (a proteolytically derived variant) to be activated by AMP suggesting that the N-
terminus was required for activation by AMP (31). Second, crystallographic structures of 
reported R-state phosphorylase b showed the N-terminus bound at the subunit interface 
with a sulfate replacing the phosphoryl group of phosphorylase a (13). New evidence 
from our lab has shown that the N-terminus is not required for activation by AMP 
(Chapter III), but that the lack of the N-terminus greatly diminishes the affinity for AMP 
and phosphate.  
It is clear that the N-terminus plays a role in establishing the kinetic properties of 
both phosphorylase a and b. However, the finding that the N-terminus is required for 
activation by sulfate but not by AMP has raised the question of whether or not activation 
by AMP is mechanistically equivalent to activation by phosphorylation. In order to 
address this question, we have made mutations to alter the interactions of the N-terminus 
with the acidic patch to either favor the binding of the N-terminus (K544E) or diminish 
the binding (E105A) as well as altering arginine 16 on the N-terminus that is poised to 
interact with these residues (66). In addition, we have examined the fluorescence 
emission from the active site cofactor in the apo and AMP bound forms of both 
phosphorylase a and b. Contrary to previous proposals, our results show that activation 
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of phosphorylase b by AMP results in an active site different from that of phosphorylase 
a. We also show modification of residues expected to support the interaction of the N-
terminus with the acidic patch enhance activity while modifications expected to 
destabilizing binding of the N-terminus to the acidic patch leads to a less active enzyme. 
These data support the hypothesis that the active form of glycogen phosphorylase b has 
the N-terminus bound at the acidic patch rather than at the subunit interface, and that the 
activations by AMP and phosphorylation are not equivalent. 
 
MATERIALS AND METHODS 
 The phosphorylase used in this study was obtained from bacterial expression of 
the recombinant rabbit muscle glycogen phosphorylase gene obtained from Robert 
Fletterick as previously described (65). Purified protein was stored at 4 ºC and generally 
used within one week. β-glycerophosphate was from Sigma-Aldrich (St. Louis, MO) or 
USB (Cleveland, OH). Restriction enzymes were from NEB (Beverly, MA). Ion 
exchange chromatography resins were from Amersham Biosciences (Piscataway, NJ). 
Size exclusion resin and glycogen phosphorylase kinase were from Sigma-Aldrich. 
Glucose-6-phosphate dehydrogenase was from Roche Applied Sciences (Indianapolis, 
IN). Phosphoglucomutase was from Roche Applied Sciences or Sigma-Aldrich. Other 
chemicals were from Sigma-Aldrich. 
Mutagenesis/Molecular Biology: The plasmid pTACTAC with the gene for wild-type 
glycogen phosphorylase gene from rabbit muscle inserted between NdeI and HindIII 
sites as previously described was used as the starting template for mutagenesis (65). The 
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mutants K544E, E105A, R16A and R16E were created by using Quik Change Site 
Directed Mutagenesis Kit (Stratagene, La Jolla, CA). K544E/∆2-17 used the previously 
described ∆2-17 phosphorylase gene in pTACTAC as the starting plasmid for 
mutagenesis (Chapter III). Resulting plasmids were sequenced to verify the mutations.  
Protein Expression and Purification: Wild-type and mutant phosphorylase were 
expressed from plasmid pTACTAC as previously described (65) with the exception that 
the growth was carried out in Escherichia coli strain DF1020 (pro-82, glnV44(AS), 
∆pfkB201, recA56, endA1, ∆(rhaD-pfkA)200, thi-1, hsdR17) (112,113) for 48 hr at 27 ºC 
in 1.5 L cultures that were inoculated with 40 ml of culture grown to saturation at 37 ºC 
in the absence of inducer. Cell pellets from expression were stored at -80 ºC prior to 
protein purification. Protein purification was carried out with modifications of 
previously described methods (65). For wild-type, cell pellets from 1.5-3 L of culture 
were thawed and resuspended in 75 mL of resuspension buffer (50 mM β-
glycerophosphate (pH 7.0), 30 mM β-mercaptoethanol, 1 mM EDTA, 0.2 mM PMSF, 
0.7 µg/mL Pepstatin A, 0.5µg/mL Leupeptin, 0.01% Benzamidine). Cells were lysed by 
sonication until the OD600 was approximately 1/10th of the starting value. Debris was 
pelleted by centrifugation at 14,000g for 45 min. The supernatant was brought to 0.5% 
polyethylenimine by addition of a 10% solution (40 mM β-glycerophosphate, 10% 
polyethylenimine), and stirred on ice for 30 min. The precipitate was removed by 
centrifugation at 14,000g for 45 min. Solid (NH4)2SO4 was added to the supernatant to 
50% saturation, and stirred on ice for 20 min. The precipitated protein was recovered by 
centrifugation at 14,000g for 30 min. The pellet was resuspended in 25 mL of column 
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buffer (25 mM β-glycerophosphate (pH 7.0), 1 mM β-mercaptoethanol, 1 mM EDTA, 
0.2 mM PMSF, 0.01% Benzamidine), and dialyzed against three changes of the same 
buffer. Protein was then run over DEAE-Sepharose fast flow and SP-Sepharose Fast 
Flow columns run in tandem. For K544E the columns were washed with 50 mM KCl in  
Column Buffer. Fractions from load and wash showing activity were pooled and used 
for subsequent kinetic and fluorescence experiments.  
 The purification of K544E/∆2-17was the same as above until the 
chromatography step. K544E/∆2-17 was loaded on a Q-Sepharose Fast Flow column 
and eluted with a 0-300 mM KCl gradient in column buffer. The cleanest fractions (as 
assessed by 10% SDS-polyacrylamide gel electrophoreses) with activity were pooled, 
dialyzed to remove salt and loaded on a DEAE-Sepharose Fast Flow column and eluted 
with a 0-300 mM KCl gradient in Column buffer. The cleanest fractions with activity 
were pooled and dialyzed to remove salt prior to use in kinetic and fluorescence studies. 
Protein was quantified using Pierce (Rockford, IL) BCA protein assay. 
Phosphorylase a: Phosphorylase a was synthesized and isolated utilizing purified 
phosphorylase b and commercially available phosphorylase kinase as previously 
described (70). 
Kinetic Measurements: Glycogen phosphorylase activity was followed in the direction 
of glycogen degradation at 25 ºC utilizing phosphoglucomutase and glucose-6-phosphate 
dehydrogenase in a coupled enzyme assay system to link the degradation of glycogen to 
the production of reduced NADPH, which was followed at 340 nm on a Beckman 600 
series UV/VIS spectrophotometer. Assays were carried out in a 600 µL reaction volume 
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containing 50 mM PIPES (pH6.8), 100 µM EDTA, 5 mg/mL rabbit liver glycogen, 0-5 
mM AMP, 0-300 mM potassium phosphate, 360 µM NADP, 4 µM glucose-1,6-
bisphosphate, 10 mM MgCl2, 6.7 U/mL phosphoglucomutase, 3 U/mL glucose-6-
phosphate dehydrogenase. Changes in ionic strength due to varying phosphate 
concentrations were compensated for by the addition of appropriate amounts of KCl. 
Temperature was maintained within 1ºC by a circulating water bath. The assay mixtures 
were preincubated at 25ºC, and the reaction was initiated by addition of appropriately 
diluted glycogen phosphorylase. 
Steady State Fluorescence: Spectral measurements were collected on an SLM-4800 
instrument with a Phoenix upgrade package from ISS (Champaign, IL). Spectra were 
collected with a 330 nm excitation wavelength at 25 ºC in a 1cm by 1cm cuvette. 
Excitation slits were set to 2 nm, and emission slits were set to 8 nm. All measurements 
were collected with protein in column buffer. The same buffer without protein was used 
as a blank to correct spectra. For experiments with AMP, 2 mM AMP was added to the 
blank as well as the sample. 
Data Analysis: Initial velocity data were plotted as titrations for both phosphate and 
AMP and individual titration curves fit to the Hill equation to determine K1/2 and Hill 
number (114). Replots of Hill number for AMP vs. phosphate were used to establish the 
homotropic coupling between AMP sites at low phosphate concentration per equation 
4.1 (101). 
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where AMPQ  is the homotropic coupling quotient in AMP binding in the absence of 
phosphate. Hn  is the Hill number for AMP binding in the absence of phosphate. 
Analogous approaches were used to establish the homotropic coupling quotient for AMP 
under saturating concentrations of phosphate. 
Quantification of the heterotropic coupling between AMP and phosphate was 
carried out with replots of K1/2 for phosphate as a function of AMP utilizing the 
thermodynamic linkage formalism of Reinhart (eq. 4.2) with the values for homotropic 
coupling in AMP binding fixed to the values established by the replots of Hill number as 
described above (101).  
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where oPiK  is the dissociation constant for phosphate in the absence of AMP. 
o
AMPK is the 
dissociation constant for AMP in the absence of phosphate. AMPQ  is the homotropic 
coupling for AMP binding in the absence of phosphate. PAMPQ / is the homotropic 
coupling for AMP binding in the saturating presence of phosphate. AMPPiQ  is the 
heterotropic coupling between AMP and phosphate. Alternatively, the coupling quotient 
AMPPiQ  can be determined directly as the ratios of K1/2 for phosphate in the absence and 
saturating presence of AMP. Free energies of coupling were calculated using the 
following relationship between Q and ∆G.  
 ∆G = -RTlnQ   (4.3) 
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Figure 4.1: The acidic patch of glycogen phosphorylase. K544, R16, and the remainder 
of the N-terminus (from residue 12) are shown in space-filling. Uncharged residues of 
the N-terminus are shown in green. Positively charged residues are shown in blue, and 
negatively charged residues are shown in red. S14 extends behind N-terminus (shown 
with dashed arrow). 
E105 
S14 
R16 
K544 
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Molecular Modeling: Graphic of acidic patch of glycogen phosphorylase was generated 
from crystal structure solved by Martin, Johnson, and Withers (Protein Data Bank 2gpb) 
using the UCSF Chimera package from the Resource for Biocomputing, Visualization, 
and Informatics at the University of California, San Francisco (supported by NIH P41 
RR-01081) (119,120). 
 
RESULTS 
The Acidic Patch: In an effort to establish the roles of the N-terminus and the acidic 
patch, mutations were made in the acidic patch to strengthen or weaken interactions with 
the N-terminus. In a reported T-state conformation, the positive charge on lysine 544 is 
shown to line up with the positive charge of arginine 16 (Figure 4.1) (66). The mutation 
K544E was made to enhance the affinity of the N-terminus at the acidic patch by 
replacing this unfavorable ionic interaction with a favorable one. The K544E mutant 
binds phosphate and AMP more tightly as can be seen as a shift down and left in the 
replot of K1/2 for phosphate as a function of AMP in Figure 4.2. The heterotropic 
coupling between AMP and phosphate was reduced slightly, though the free energy of 
coupling remains within error (Figure 4.3 and Table 4.1). Fitting of the curve shown in 
Figure 4.4A shows that the binding affinity for the first equivalent of AMP is reduced 
somewhat, however there is also an enhancement in homotropic cooperativity in AMP 
binding (Figure 4.5). The net result is that there is a significant reduction in K1/2 for 
AMP with the K544E mutation (Figure 4.4B). The mutation K544E is predicted to  
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KoPi a,e 
(mM) 
KoAMP c,e 
(mM) 
QAMPPid,e kcat  
(s-1) 
nHPig 
- AMP 
+AMP 
nHAMPh 
- Pi 
+Pi 
Wild-type bb 940±40 0.44±0.02 92±5 40±2 1.90±0.05 1.14±0.01 
1.52±0.05 
1.11±0.03 
Wild-type a 21±1 ND 1.7f 51±1 1
i 
1i 
1i 
1i 
K544E 430±30 1.82±0.08 53±4 8.9±0.2 1.88±0.02 1.07±0.02 
1.90±0.05 
1.46±0.03 
E105A 1160±80 3.39±0.08 86±6 46±5 1.98±0.06 1.05±0.04 
1.95±0.06 
1.63±0.03 
R16A 118±1 0.093±0.004 10.40±0.02 16.7±0.3 1.63±0.05 1.15±0.01 
1.42±0.05 
1.02±0.02 
R16E 77±4 0.024±0.002 6.3±0.3 24.4±0.5 1.31±0.03 1.07±0.03 
1.23±0.02 
1.06±0.06 
 
 
Table 4.1: Kinetic constants for wild-type and acidic patch mutants of glycogen 
phosphorylase b.  
a Dissociation constant for phosphate in absence of AMP. b Initial affinity for phosphate value differ from values reported in 
Chapter III (and consequently the coupling quotient value) due to a change in glycogen lot used. Values are constant with a 
given lot of glycogen, but vary from lot to lot. c Dissociation constant for the first equivalent of AMP in the absence of 
phosphate. d Coupling quotient between phosphate and AMP. e Determined from fitting replots of K1/2 for phosphate vs. AMP 
to equation 4.2. f Determined directly from ratio of affinity for phosphate in the absence and saturating presence of AMP rather 
than by curve fitting. g Hill number in phosphate binding in the absence and saturating presence of AMP. h Hill number in 
AMP binding in the absence and saturating presence of phosphate. i No homotropic cooperativity is obsereved with 
phosphorylase a. 
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Figure 4.2: Replot of K1/2 for phosphate as a function of AMP 
for wild-type and acidic patch mutants. K1/2 data were 
determined from fitting phosphate titrations at constant AMP to 
the Hill equation. Data are shown for wild-type (•), K544E ( ), 
E105A (ο), R16A (∆), R16E (∇). Lines represent best fit to 
equation 4.2 with the homotropic coupling quotients for AMP 
fixed to the values calculated from the Hill numbers observed 
in AMP binding. Experiments carried out at 25°C under 
constant ionic strength. Glycogen was at 5 mg/ml. 
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Figure 4.3: Heterotropic free energy of coupling between AMP 
and phosphate for wild-type and acidic patch mutants of glycogen 
phosphorylase. ∆GAMPPi are calculated from QAMPPi determined 
from fitting of replots of K1/2 for phosphate as a function of AMP 
to equation 4.2. 
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Figure 4.4: Affinity for AMP at low concentrations of 
phosphate for wild type and acidic patch mutants. A) 
The binding affinity of first equivalent of AMP as found 
from fits of the replot of K1/2 for phosphate as a function 
of AMP is shown for wild-type and each mutant. B) The 
binding affinity for AMP determined from titrations of 
AMP at low concentrations of phosphate is shown for 
wild-type and each mutant. The tighter binding shown in 
B is the result of homotropic cooperativity in AMP 
binding. 
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Figure 4.5: Free energies of homotropic coupling for 
wild-type and acidic patch mutants. A) The homotropic 
coupling in phosphate binding. B) The homotropic 
coupling in AMP binding. Cross hatched columns are in 
absence of other ligand. Filled columns are in the 
saturating presence of other ligand. Values come from 
averaging the Hill numbers at the limits of replots of Hill 
number as a function of the other ligand. Conversion to 
free energy was done using relationships in equations 
4.1 and 4.3. Error bars are standard error of averages.  
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support binding of the N-terminus to the acidic patch. To rule out the possibility that the 
effect of K544E was simply an effect on overall protein structure, the K544E mutant was 
combined with a truncate lacking the N-terminus. It was found that in the absence of the 
N-terminus the kinetics closely resembled the truncate alone (data not shown). 
 Glutamate 105 makes favorable contacts with arginine 16 at the acidic patch. To 
test the effect of weakening the binding of the N-terminus at the acidic patch the mutant 
E105A was constructed. Contrary to what was seen with the K544E mutant, the replots 
of K1/2 for phosphate as a function of AMP for the E105A mutant show a curve that is 
shifted up and over to the right indicating a weakening of binding for both AMP and 
phosphate (Figure 4.2). Indeed, the kinetic constants determined for E105A show this 
mutant does bind to AMP and phosphate with less affinity than wild-type (Table 4.1 and 
Figure 4.4).  The heterotropic coupling between AMP and phosphate remain similar to 
wild-type, while there is an enhancement in homotropic cooperativity for the binding of 
both AMP and phosphate. 
Arginine 16: The effects of both K544E and E105A are expected to be mediated 
through an interaction with arginine 16. For purposes of comparison position 16 was 
mutated to both alanine and glutamate. As can be seen in Figure 4.2 both mutants 
enhance the binding of phosphate in the absence of AMP with the effect of R16E being 
stronger than that of R16A. Likewise both position 16 mutants show an enhanced 
binding to AMP (Table 4.1 and Figure 4.4). There is a reduction in the heterotropic 
coupling seen between AMP and phosphate as well as reduced homotropic cooperativity 
in both AMP and phosphate binding with both mutants which is all consistent with the 
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apo state of these mutants more closely resembling the fully saturated form (Figures 4.3 
and 4.5). 
 Inspection of Figure 4.2, demonstrates that while the mutants tested have a wide 
range of effect on the affinity for phosphate in the absence of AMP, the curves all 
converge to similar values in the saturating presence of AMP. This observation is 
consistent with the N-terminus affecting the initial affinity for phosphate but not the 
activation by AMP. This idea is further lent support by comparison of the results of 
homotropic cooperativities particularly in the absence of the other ligand. In all cases, 
mutants that enhanced affinity diminished the homotropic cooperativity, while mutants 
that diminished affinity also enhanced homotropic cooperativity for that mutant. The 
results with K544E and E105A would seem to indicate that stabilizing the N-terminus at 
the acidic patch stabilizes the active state of the enzyme. This is contrary to the notion 
that activation by phosphorylation and AMP result in similar conformations with the N-
terminus bound at the subunit interface.  
Fluorescence of Phosphorylase a and b: To further investigate the differences by AMP 
and phosphorylation, fluorescence spectroscopy was utilized to examine the cofactor at 
the active site for each (Figure 4.6). High concentrations of phosphorylase a were 
unobtainable due to the propensity to crystallize at higher concentrations (89), and the 
lower concentration of protein resulted in the emission spectra for phosphorylase a being 
far more noisy.  It is clear, however, that the emission spectra differ between 
phosphorylase a and b in the absence and presence of AMP as well as in the observed 
response to AMP binding. The two peaks observed are due to the two conformations of 
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Figure 4.6: Steady-state fluorescence 
emission spectra of wild-type glycogen 
phosphorylase cofactor excited at 330 
nm. A) The emission of phosphorylase 
b. B) The emission from phosphorylase 
a. Solid line is apo emission. Dotted 
line is with 2 mM AMP. Change seen 
in A is by far the most dramatic 
observed. 
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cofactor (121). The lower wavelength peak is due to the enol form of the cofactor, while 
the higher wavelength peak is due to the keto form, and the ratio between forms is 
sensitive their environments. The relative emission from the enol and keto peaks of 
phosphorylase a and b have been shown to vary significantly between protein 
preparations. However, it has been found that the relative positions of  the peaks are 
consistent between purifications and independent of AMP.  It can be seen that 
phosphorylation shifts the peaks closer together (approximately 400 nm and 520 nm for 
b form and 410 nm and 510 nm for a form). The addition of AMP to phosphorylase b 
does not induce such a shift. Addition of AMP does however induce a reduction in enol 
form emission and an increase in keto form emission from phosphorylase b. This 
diminishing of the enol emission with addition of AMP to phosphorylase b occurred 
with different preparations of phosphorylase b, however the magnitude of the change is 
clearly dependent on the relative amount enol form in the apo enzyme. Figure 4.6A 
shows the most dramatic difference observed. This effect on the ratio between peaks is 
not seen on addition of AMP to phosphorylase a, however an overall increase in 
intensity was noted.  
 
DISCUSSION 
 The accepted structural mechanism of glycogen phosphorylase activation 
involves the movement of the N-terminus from the acidic patch to the subunit interface 
(13). Our previous results have shown that this could not be completely true due to the 
full activation seen in the absence of the N-terminus (Chapter III). It is clear, however, 
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that the N-terminus has a profound effect on the initial affinities for both phosphate and 
AMP. The findings with K544E and E105A are inconsistent with the idea that the N-
terminus occupies the acidic patch only in the inactive state of the enzyme. K544E was 
expected to stabilize the binding of the N-terminus at the acidic patch. K544E has a less 
dramatic effect than mutations at position 16, however it similarly brought about a more 
active enzyme without a loss of homotropic cooperativity. E105A, which was expected 
to weaken the interaction between the N-terminus and the acidic patch, produces an 
enzyme that has a reduced affinity for both effector and substrate. It is interesting to note 
that position 105 in the liver isozyme, which is less sensitive to AMP regulation, has a 
neutral glutamine residue and is the only position in the acidic patch not conserved 
between the liver and muscle isozymes(2). 
Data for the R16E mutation has been previously reported as single AMP 
activation curves in the direction of glycogen synthesis (89). We show here that the 
kinetic values measured, specifically total activity, affinity for substrate and effector, and 
Hill numbers, are functions of both effector and substrate making comparison to the 
previous work difficult. Overall, both the previous work and this report show that 
mutation of position 16 results in a more active phosphorylase b. Similar results were 
found with mutations that placed a negative charge at position 14 (70). However, both of 
these previous works speculated that the observed results were due to an enhanced 
interaction of the N-terminus at the subunit interface therefore bringing about a more 
phosphorylase a like structure.  
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The results reported here indicate that the binding of the N-terminus to the acidic 
patch may in fact enhance the affinities for both AMP and phosphate in the absence of 
the other while not affecting the final activated state. Examination of the crystal structure 
reveals that removal of the positive charge at position 16 could in fact have a favorable 
effect on binding at the acidic patch due to the relief of ionic clash with K544. It could 
not have been predicted whether or not the alanine mutation at position 16 would have 
enhanced the binding of the N-terminus to the acidic patch due to the loss of both 
favorable and unfavorable ionic interactions. The acidic patch has a negative overall 
charge, but there are potential interactions with positive residues for a negative charge at 
position 16 which could explain the effects seen with R16E. Detailed structural 
considerations indicate that the results seen with mutants at position 16 may not come 
from an enhanced interaction of the N-terminus at the subunit interface as previously 
proposed, but rather from an enhanced interaction at the acidic patch. 
 It is important to note that an enhanced interaction at the subunit interface, 
specifically at the phosphoserine recognition site, would be expected to activate 
phosphorylase b. This has been demonstrated through sulfate activation (61). However, 
sulfate activation is dependent on the N-terminus and gives a concomitant loss of 
homotropic cooperativity and increases the observed activity in the absence of AMP 
(61,62). The results with the acidic patch mutants are intriguing due to their seeming 
inverse nature with respect to the proposed role of the acidic patch (13). These results 
would indicate that the binding of the N-terminus at the acidic patch enhances the 
affinities for phosphate and AMP which could help explain how polyamines activate 
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phosphorylase b. None of these mutations seem to have a significant effect on the AMP 
saturated state of the enzyme which is in agreement with the finding that phosphorylase 
can be fully activated by AMP in the absence of the N-terminus. The affinity for 
phosphate under saturating AMP concentration for all of the mutants tested is nearly 
equal to the affinity for substrate seen with phosphorylase a under similar conditions. 
The effect of the N-terminus seems to be in determining the affinity for phosphate and 
AMP in the absence of the other, and there is a strong implication that the N-terminus 
interacting with the acidic patch enhances those affinities.  
 If activation by AMP does indeed involve binding of the N-terminus to the acidic 
patch, that would be a strong indication that activation by AMP is not structurally 
equivalent to activation by phosphorylation. Supporting this idea are the data presented 
here showing that the fluorescence from the active site cofactor is affected differently by 
phosphorylation and AMP. In addition, glycogen phosphorylase b is a K-type system. 
Both with wild-type and all mutants tested here there is no dependence of Vmax on the 
concentration of AMP present. However, it is well recorded in the literature and has 
been observed in our studies that phosphorylase a has a significantly higher Vmax (61,68). 
Only E105A did not show a decrease in Vmax for the mutant enzyme when compared to 
wild-type. None of the mutations that were proposed to bring about a phosphorylase a-
like structure have the hallmarks of phosphorylase a that include a lose of homotropic 
cooperativity and an increase in Vmax (63). To date all the data observed can be explained 
by the notion that the active form of phosphorylase b has the N-terminus occupying the 
acidic patch. It is important to realize, however, that if this suggestion is correct then 
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activation could be realized by either enhanced binding at the acidic patch or at the 
subunit interface, and the AMP activated form of phosphorylase b does not require 
either, but the initial affinity for substrate and effector is enhanced by the N-terminus 
interacting with the acidic patch.   
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CHAPTER V 
THE FUNCTION OF THE 280’s LOOP AND α-HELIX 1 IN THE 
ACTIVATION OF GLYCOGEN PHOSPHORYLASE b: 
CONFIRMATION OF THEIR ROLES IN ALLOSTERY 
 
BACKGROUND 
  Glycogen phosphorylase catalyzes the breakdown of glycogen stores (2). In the 
mammalian system, there are three isozymes that vary in their regulation with the most 
extensively studied being the muscle enzyme from rabbit. The structure of glycogen 
phosphorylase is well known from crystallographic studies. The catalytically active form 
of the enzyme is a dimer with a molecular mass of 97.5 kDa per subunit (8,63). The 
subunit itself can be divided into 2 domains, the N-terminal regulatory domain and the 
C-terminal catalytic domain. The active site lies in a cleft between the two domains of 
the subunit and contains the required cofactor pyridoxial-5-phosphate. It has been 
proposed that access to the active site is controlled in part by the positioning of residues 
280-286 (the 280’s loop) along this cleft, and in the closed conformation the active site 
is cut off from solvent (13). 
Physiologically, glycogen phosphorylase must be activated to carry out its 
function. Activation can come via the phosphorylation of serine 14 yielding the more 
active species phosphorylase a (the unphosphorylated form is known as phosphorylase 
b)(63). Phosphorylation results in the N-terminus (residues 1-22) moving to the subunit 
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interface where the phosphoserine recognition site is located (13). Activation can also be 
achieved via the binding of AMP to the allosteric sites, though AMP activation only 
induces the enhanced affinity for substrate, not the increase in Vmax observed upon 
conversion to phosphorylase a (Chapter IV). The addition of AMP to phosphorylase a 
has also been shown to enhance substrate affinity though it is a much smaller effect 
compared to the effect of AMP has on phosphorylase b (63). Glycogen phosphorylase 
can be inhibited by purines which occurs via binding at the apex of the active site cleft 
(2,8). Various inhibitors, including ATP, caffeine and at high concentrations AMP, bind 
with concomitant aromatic stacking between F285 and Y613 (8). 
The extensive structural work that has been done with glycogen phosphorylase 
has led to proposals on the roles of the subunit interface, the N-terminus, and the 280’s 
loop. The subunit interface is made up of two sets of interactions (13). First, the tower 
helices (α-helix 7) interact with their counterparts across the interface (Figure 5.1A). On 
the opposing side of the interface, α-helix 1 (residues 23-35) and α-helix 2 (residues 48-
78) act as a group to make up the remainder of the interface (Figure 5.1B). Between α-
helix 1 and 2 is the cap loop (residues 36-47) which is seen lying across the top of the 
allosteric site in the AMP activated enzyme (13). It has been proposed that this 
interaction between the cap loop and AMP causes a shift in α-helix 2 which rearranges 
the interface and causes a rotation between subunits that activates the enzyme. This shift 
has focused attention on the role of α-helix 2 in the allosteric activation by AMP while 
the roles of α-helix 1 and the tower helices have been thought to be somewhat 
consequential to the movement of α-helix 2.  
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Figure 5.1: Dimeric structure of glycogen phosphorylase b inhibited by glucose. Subunit 1 is 
colored light grey. Subunit 2 is colored dark grey. α-helices 1 and 2 are shown in blue for 
subunit 2 and pink for subunit 1. Tower helices are shown in yellow. Active site cofactor is 
shown in green. N-terminus is shown in forest green. The 280’s loop is shown in orange. A) 
View of active site face of dimer showing the 280’s loop at the active site cleft. Residues 
interacting with the 280’s loop that were mutated are shown in light blue. F285 on the 280’s 
loop is shown in dark blue. B) View of the dimer from the back of the enzyme. Residues 
mutated are shown in space-filling. A19 in green is on the N-terminus. N23, K29, and R33 are 
shown in pink on α-helix 1 of one monomer and blue on the other. Only one subunit is labeled 
for clarity. 
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 The reported T-state of phosphorylase b shows the 280’s loop bound across the 
opening to the active site with a direct interaction between F285 and Y613 (13). In 
addition, the side chain of D284 was seen to point into the active site and occupies the 
site where phosphate binds during catalysis. The positioning of a negative residue at this 
site is proposed to prevent the binding of substrate in the inactive state. In the R-state 
structures, the 280’s loop is displaced allowing solvent access to the active site, and 
R569 occupies the site previously held by D284 (13). This exchange has been 
hypothesized as one of the key mechanisms to the activation of the enzyme, along with 
the opening of the active site. However, a similar mechanism to allostery was ruled out 
in phosphofructokinase (6). The role of the 280’s loop has been examined previously by 
site directed mutagenesis of the residues in the loop itself (73). Unfortunately, such 
mutations had severe consequences on the activity of the enzyme and ultimately the 
authors acknowledged that the mutants behaved differently, but the differences could not 
be ascribed to a change in allostery. 
In this study, we have focused on the roles of α-helix 1 and the 280’s loop in 
activation of glycogen phosphorylase b by AMP. Residues of α-helix 1 that differ 
between the isozymes of phosphorylase have been modified. To overcome the 
compromised activity seen on modification of the 280’s loop, this study has focused on 
the residues making contact with the 280’s loop when it is bound across the entry to the 
active site. In addition, residue A19, which is on the N-terminus, and residue F285, 
which is in the 280’s loop and part of the purine inhibition site, were examined. Mutants 
of α-helix 1 predominately exhibited effects on homotropic cooperativity rather than 
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heterotropic activation by AMP. Some of the 280’s loop mutants have dramatic effects 
on the activity of the enzyme, but others have far less dramatic effects. The allostery of 
these mutants is significantly altered from wild-type revealing that indeed the 280’s loop 
has a major role in the activation by AMP. 
 
MATERIALS AND METHODS 
 The phosphorylase for this study was obtained from bacterial expression of the 
recombinant rabbit muscle glycogen phosphorylase gene as previously described (65). 
Purified proteins were stored at 4 ºC and generally used within one week. β-
glycerophosphate was from Sigma-Aldrich (St. Louis, MO) or USB (Cleveland, OH). 
Restriction enzymes were from New England Biolabs (Beverly, MA). Ion exchange 
chromatography resins were from Amersham Biosciences (Piscataway, NJ). Size 
exclusion resin and glycogen phosphorylase kinase were from Sigma-Aldrich. Glucose-
6-phosphate dehydrogenase was from Roche Applied Sciences (Indianapolis, IN). 
Phosphoglucomutase was from Roche Applied Sciences or Sigma-Aldrich. Rabbit liver 
glycogen from Sigma-Aldrich was used in the kinetic experiments. Other chemicals 
were from Sigma-Aldrich. 
Mutagenesis/Molecular Biology: The plasmid pTACTAC with the gene for wild-type 
glycogen phosphorylase gene from rabbit muscle inserted between NdeI and HindIII 
sites as previously described was used as the starting template for mutagenesis (65). The 
phosphorylase mutants A19V, N23D, E26A, K29A, R33A, F285A, E287A, W387A, 
R569A, H571A, Y613A, and Y613H were created using a Quik Change Site Directed 
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Mutagenesis Kit (Stratagene, La Jolla, CA). Resulting plasmids were sequenced to 
verify the mutations.  
Protein Expression and Purification: Wild-type and mutant phosphorylase were 
expressed from plasmid pTACTAC as previously described (65) with the exception that 
the growth was carried out in E. coli strain DF1020 (pro-82, glnV44(AS), ∆pfkB201, 
recA56, endA1, ∆(rhaD-pfkA)200, thi-1, hsdR17)(9,10)  for 48 hr at 27 ºC in 1.5 L 
cultures that were inoculated with 40 ml of culture grown to saturation at 37 ºC in the 
absence of inducer. Cell pellets from expression were stored at -80 ºC prior to protein 
purification. Protein purification was carried out with modifications of previously 
described methods (8). Briefly, cell pellets from 1.5-3 L of culture were thawed and 
resuspended in 75 mL of resuspension buffer (50 mM β-glycerophosphate (pH 7.0), 30 
mM β-mercaptoethanol, 1 mM EDTA, 0.2 mM PMSF, 0.7 µg/mL pepstatin A, 0.5 
µg/mL leupeptin, 0.01% benzamidine). Cells were lysed by sonication until the OD600 
was approximately 1/10th of the starting value. Debris was pelleted by centrifugation at 
14,000 g for 45 min. The supernatant was brought to 0.5% polyethylenimine by addition 
of a 10% solution (40 mM β-glycerophosphate, 10% polyethylenimine), and stirred on 
ice for 30 min. The precipitate was removed by centrifugation at 14,000 g for 45 min. 
Solid (NH4)2SO4 was added to the supernatant to 50% saturation, and stirred on ice for 
20 min. The precipitated protein was recovered by centrifugation at 14,000 g for 30 min. 
The pellet was resuspended in 25 mL of column buffer (25 mM β-glycerophosphate (pH 
7.0), 1 mM β-mercaptoethanol, 1 mM EDTA, 0.2 mM PMSF, 0.01% benzamidine), and 
dialyzed against three changes of the same buffer. The protein was then applied to 
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DEAE-Sepharose Fast Flow and SP-Sepharose Fast Flow columns run in tandem. 
Fractions from the load and wash showing activity were pooled and used for subsequent 
kinetic and fluorescence experiments. Protein was quantified using Pierce (Rockford, IL) 
BCA protein assay. 
Kinetic Measurements: Glycogen phosphorylase activity was followed in the direction 
of glycogen degradation at 25 ºC utilizing phosphoglucomutase and glucose-6-phosphate 
dehydrogenase in a coupled enzyme assay system to link the degradation of glycogen to 
the production of reduced NADPH, which was followed at 340 nm on a Beckman 600 
series UV/VIS spectrophotometer. Assays were carried out in a 600 µL reaction volume 
containing 50 mM PIPES (pH6.8), 100 µM EDTA, 5 mg/ml rabbit liver glycogen, 0-5 
mM AMP, 0-300 mM potassium phosphate, 360 µM NADP, 4 µM glucose-1,6-
bisphosphate, 10 mM MgCl2, 6.7 U/mL phosphoglucomutase, 3 U/mL glucose-6-
phosphate dehydrogenase. Changes in ionic strength due to varying phosphate 
concentrations were compensated for by the addition of appropriate amounts of KCl. 
Temperature was maintained within 1 ºC by circulating water bath. The assay mixes 
were preincubated at 25 ºC, and the reaction was initiated by addition of appropriately 
diluted glycogen phosphorylase. 
Data Analysis: In order to quantify homotropic and heterotropic couplings, initial 
velocity data were plotted as titrations of both phosphate and AMP and individual 
titration curves fit to the Hill equation to determine the K1/2 and Hill number in binding 
(114). The homotropic coupling quotient for AMP binding in the absence of phosphate 
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was determined from the limit value of the Hill number at low phosphate observed in 
replots of Hill number for AMP vs. phosphate according to equation 5.1 (101). 
 
2
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



−
=
H
H
AMP n
nQ   (5.1) 
where AMPQ  is the homotropic coupling quotient for AMP binding in the absence of 
phosphate. Hn  is the Hill number for AMP binding in the absence of phosphate. 
Analogous approaches were used to determine the homotropic coupling quotient for 
AMP in the saturating presence of phosphate and the homotropic coupling quotient for 
phosphate binding in the absence and presence of AMP. 
Quantification of the heterotropic coupling between AMP and phosphate was 
carried out with replots of K1/2 for phosphate as a function of AMP utilizing the 
thermodynamic linkage approach described by Reinhart (101) (equation 5.2) with the 
values for homotropic coupling in AMP binding fixed to the values established by the 
replots of Hill number.  
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where oPiK  is the dissociation constant for phosphate in the absence of AMP. 
o
AMPK is the 
dissociation constant for AMP in the absence of phosphate. AMPQ  is the homotropic 
coupling quotient for AMP binding in the absence of phosphate. PAMPQ / is the homotropic 
coupling quotient for AMP binding in the saturating presence of phosphate. AMPPiQ  is the 
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observed heterotropic coupling quotient between AMP and phosphate and can 
alternately be defined as;  
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where 
)( AMPPi
Q  is the true heterotropic coupling between AMP and phosphate. pAMPQ / is 
the homotropic coupling quotient in AMP binding with only one equivalent of phosphate 
bound.  Alternatively, the coupling quotient AMPPiQ  can be determined directly as the 
ratios of K1/2 for phosphate in the absence and saturating presence of AMP. Free 
energies of coupling were calculated using the relationship between Q and ∆G.  
 ∆G = -RTlnQ (5.4) 
Molecular Modeling: Graphics of glycogen phosphorylase were generated from crystal 
structure solved by Martin, Johnson, and Withers (Protein Data Bank 2gpb) using the 
UCSF Chimera package from the Resource for Biocomputing, Visualization, and 
Informatics at the University of California, San Francisco (supported by NIH P41 RR-
01081) (119,120). 
 
RESULTS 
 All mutants were successfully created and expressed. However the variants 
E26A, R569A and Y613A gave no measurable activity. H571A gave detectible activity 
but it was reduced more than 200-fold with respect to wild-type and as a result kinetic 
parameters could not be verifiably established. For the remaining variants the effects on 
Vmax, with the exception of Y613H, were less than 4-fold (Table 5.1).
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KoPi a,d 
(mM) 
KoAMP b,d 
(mM) 
QAMPPic,d kcat 
(s-1) 
nHPie 
-AMP 
+AMP 
nHAMPf 
-Pi 
+Pi 
Wild-type b 940±40 0.44±0.02 92±5 41±2 1.9±0.05 1.14±0.01 
1.52±0.05 
1.11±0.03 
A19V 244±1 .85±0.03 25.5±0.7 42±2 1.84±0.16 1.04±0.02 
1.74±0.05 
1.31±0.06 
N23D 7000±1000 1.47±0.06 500±100 24.7±0.5 1.13±0.01 1.01±0.01 
1.86±0.02 
1.66±0.06 
K29A 1700±100 1.05±0.03 160±10 32.7±0.3 1.70±0.01 1.15±0.01 
1.61±0.07 
1.54±0.02 
R33A 4700±600 4.6±0.2 470±60 32±0.5 1.48±0.03 1.16±0.02 
1.74±0.03 
1.53±0.04 
       
F285A 1300±100 2.8±0.1 19±2 10.9±0.3 1.88±0.01 1.20±0.03 
1.93±0.06 
1.56±0.04 
E287A 86±1 0.018±0.001 10.4±0.3 22.9±0.2 1.37±0.04 1.08±0.02 
1.07±0.04 
1.10±0.02 
W387A 260±10 0.0091±.0007 7.6±0.3 9.4±0.2 1.35±0.03 1.02±0.02 
1.07±0.04 
1.07±0.04 
Y613H 4000±2000 0.17±.02 70±40 0.93±0.07 1.81±0.05 1.15±0.22 
1.18±0.02 
1.63±0.03 
a The dissociation constant for phosphate in the absence of AMP. b The dissociation constant for the binding of the first 
equivalent of AMP in the absence of phosphate. c The ratio of the dissociation constant for phosphate in the absence and 
saturating presence of AMP. d Determined form fitting of replots of K1/2 for phosphate vs. AMP to equation 5.2. e Determined 
form fitting phosphate titrations at high and low concentrations of AMP to the Hill equation. f Determined by fitting AMP 
titrations at high and low concentrtions of phosphate to the Hill equation. 
Table 5.1: Kinetic constants for wild-type, α-helix 1, and 280’s loop mutants of 
glycogen phosphorylase b.  
104 
 
α-Helix 1 Mutants: The variants N23D, K29A and R33A (collectively referred to as the 
α-helix 1 mutants) have varying effects on the kinetics of the enzyme. They all show a 
weaker affinity for phosphate in the absence of AMP as well as a weaker affinity for 
AMP (Figures 5.2 and 5.3A and Table 5.1). A19V, which is on the N-terminus, is a 
more complex case. The affinity for phosphate is improved in the absence of AMP. The 
binding affinity for the first equivalent of AMP is reduced but that is offset by an 
increase in homotropic cooperativity in AMP binding meaning that the overall affinity 
for AMP is greater than that of wild-type (Figure 5.4C). Homotropic coupling in AMP 
binding for the α-helix 1 mutants in absence of phosphate is greater than or similar to 
that of wild-type. The cooperativity in AMP binding in the presence of phosphate was 
greatly enhanced compared to wild-type (Figure 5.4C). For all of the α-helix 1 mutants, 
the homotropic cooperativity in phosphate binding is diminished compared to wild-type 
with and without AMP, but the larger change is observed in the absence of AMP. All of 
the α-helix 1 mutants are activated to a similar functional state as wild-type by AMP, as 
can be seen by the convergence of curves to a similar point at the right side of Figure 
5.1.  
280’s Loop Mutants: Mutagenesis of the 280’s loop binding partners, E287A, W387A, 
and Y613H, as well as F285A was done with the expectation of reducing the binding of 
the 280’s loop at the active site cleft. The effects on the activation by AMP were then 
assessed. Replots of K1/2 for phosphate as a function AMP for the 280’s loop mutants 
show a much different pattern than that observed with the α-helix 1 mutants. The 
disruption of the 280’s loop caused significant changes in affinity for phosphate in both  
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Figure 5.2: Replot of K1/2 for phosphate as a function of AMP 
for wild-type, A19V and α-helix 1 mutants. Data is shown for 
wild-type (•), A19V (∇), N23D ( ), K29A (∆), and R33A (ο). 
K1/2 data were determined from fitting individual phosphate 
titrations at constant AMP to the Hill equation. Lines represent 
best fit to Equation 5.2 with homotropic coupling quotients for 
AMP fixed to the values calculated from the Hill number for 
AMP binding in the absence and presence of phosphate. 
Experiments carried out with 5 mg/ml glycogen at 25°C. 
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Figure 5.3: AMP binding affinity in the absence of phosphate for α-helix 1 and 280’s loop 
mutants. Open bars are affinity for the first equivalent of AMP determined from fitting 
replots of K1/2 for phosphate vs. AMP to equation 5.2 (KoAMP). Hatched bars are K1/2 for 
AMP at low phosphate determined from fitting AMP titration at fixed phosphate to the Hill 
equation. A) AMP affinities for α-helix one mutants and A19V. B) AMP affinities for 
280’s loop mutants. 
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Figure 5.4: Homotropic free energy of coupling for wild-type, α-helix 1, and 
280’s loop mutants of glycogen phosphorylase b. Free energies of homotropic 
coupling are calculated from the Hill number in ligand binding determined by 
fitting titration curves to the Hill equation. A) Free energy of coupling in 
phosphate binding for α-helix 1 mutants and A19V. B) Free energy of coupling in 
phosphate binding for 280’s loop mutants. A & B) Free energy of coupling in 
absence of AMP is shown as filled bar. Free energy of coupling in the saturating 
presence of AMP is shown as bars with diagonal lines. C) Free energy of coupling 
in AMP binding for α-helix 1 mutants and A19V. D) Free energy of coupling in 
AMP binding for 280’s loop mutants. C & D) Open bars are free energy of 
coupling in absence of phosphate. Cross hatched bars are free energy of coupling 
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the apo and the AMP saturated states of the enzyme (Figure 5.5). E287A and W387A 
improved the affinity for phosphate in the absence of AMP, while F285A and Y613H 
diminished the affinity for phosphate (Table 5.1). All, except F285A, improved the 
binding of AMP to the enzyme (Figure 5.2B). The affinity for the first equivalent of 
AMP and the observed K1/2 for AMP nearly agree for three of the mutants (Figure 5.2). 
Examination of the homotropic cooperativity in AMP binding for the E287A, W387, and 
Y13A variants reveals that there is little to no cooperativity in these mutants meaning 
that the affinity for the first equivalent should match the measured K1/2, as is observed 
(Figure 5.3). The F285A variant has greater homotropic cooperativity in AMP binding. 
All of the 280’s loop mutants diminished homotropic cooperativity in phosphate binding 
to some degree, but it is observed that the variants that improve the binding of phosphate 
(E287A and W387A) diminished the homotropic cooperativity in phosphate binding to a 
greater extent than the variants that decreased the affinity for phosphate (F285A and 
Y613H). The maximal activity of these mutants is affected to varying degrees. Y613H 
shows a 40-fold decrease whereas the E287A shows less than a two-fold change. All of 
the 280’s loop mutants show a decrease in heterotropic coupling between phosphate and 
AMP. It was also found in this study that Y613H yielded the smallest change in 
heterotropic coupling between AMP and phosphate, while E287A showed a much 
greater alteration in heterotropic coupling without a dramatic loss of activity. (Table 
5.1).  
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Figure 5.5: Replot of K1/2 for phosphate as a function of 
AMP for wild-type and 280’s loop mutants. Data are 
shown for wild-type (ο), F285A (•), E287A (), W387A 
(), Y613H ().K1/2 data were determined from fitting 
individual phosphate titrations at constant AMP to the 
Hill equation. Lines represent best fit to Equation 5.2 
with homotropic coupling quotients for AMP fixed to 
the values calculated from the Hill number for AMP 
binding in the absence and presence of phosphate. 
Experiments carried out with 5 mg/ml glycogen at 25°C. 
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DISCUSSION 
 The 280’s loop has long been thought to be important for activation of glycogen 
phosphorylase (13,73). The potential to act as a cap to the active site thereby sealing it 
off from substrates, and the finding that purine inhibitors bind and stabilize the 280’s 
loop in the active site cleft, makes the 280’s loop a prime candidate for the regulation of 
substrate binding. The previous study that attempted to address this hypothesis focused 
on alterations of the 280’s loop residues and found that the apparent regulation was 
significantly different from wild-type (73). Unfortunately, the observed changes in 
properties could not be attributed to a change in allostery because the maximal activity 
of the enzymes was greatly compromised. The alternate approach taken here has 
identified mutants that are expected to alter the ability of the 280’s loop to bind in the 
active site cleft without compromising the activity of the enzyme dramatically. This 
search discovered numerous mutations that completely inactivated the enzyme, as well 
as some that retained extremely low activities, which again highlights the importance of 
this region for the activity of phosphorylase. Other mutations identified did not have 
such dramatic effects on the specific activity, but did significantly alter the response to 
AMP. E287A and W387A in particular nearly eliminate both heterotropic and 
homotropic communication between sites while maintaining significant activity. This 
finding implicates the 280’s loop in the allosteric regulation of glycogen phosphorylase 
b. The dramatic effect on homotropic communication shows that communication across 
the subunit interface has been compromised. While it was not specifically addressed by 
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this study, it is tempting to speculate that the communication being disrupted is via the 
tower helices that directly connect the 280’s loop to the subunit interface (13).  
 Comparison of Figures 5.1 and 5.4 shows that the 280’s loop and the α-helix 1 
mutants have dramatically different effects on phosphorylase b. Mutations of the 280’s 
loop affected the affinity for phosphate in both the apo and AMP saturated states of the 
enzyme whereas the α-helix 1 mutations only appear to affect the affinity in the apo 
enzyme.  
Mutations of α-helix 1 primarily have effects on the homotropic cooperativity. 
All of the α-helix 1 mutations dramatically diminish homotropic cooperativity in 
phosphate binding indicating that the communication between active sties is lost. Also, 
phosphate is no longer able to relieve the homotropic cooperativity in AMP binding, 
indicating that communication between active site and allosteric site has been lost. It has 
been shown structurally that α-helix 1 and 2 shift on AMP binding. The same shift 
would be expected to be brought on by the binding of phosphate to the apo enzyme due 
to the ability of phosphate to enhance the affinity for AMP in the wild-type enzyme and 
relieve the homotropic cooperativity in AMP binding. It may be that this shift of α-
helices 1 and 2 is no longer possible upon phosphate binding with the modified α-helix 1 
residues, resulting in homotropic cooperativity in AMP binding even in the presence of 
high phosphate. Similarly, it is understandable that in the absence of such a shift, binding 
of a single phosphate could no longer activate the other subunit due to a lack of the 
reinforcing effect of the shift of α-helix 1 and 2 at the subunit interface.  
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Similarly, a study that mutated P48 in α-helix 2 found a loss of homotropic 
communication in AMP binding (68). Despite this, variants at position 48 maintained 
activation by AMP. Some of the mutants actually showed tighter binding for AMP even 
without homotropic cooperativity. These results may indicate that the shift of α-helix 1 
and 2 at the interface had already occurred in the apo enzyme.  
AMP still seems to fully activate the α-helix 1 mutants, despite the apparent loss 
of communication caused by modification of the α-helix 1 residues. The heterotropic 
coupling between AMP and phosphate is in fact greater for these mutants. However, the 
reduction in homotropic cooperativity in phosphate binding is expected to cause an 
apparent increase in the dissociation constant for phosphate in the absence of AMP. The 
expected behavior is observed in Figure 5.1 as the elevated K1/2 for phosphate in the 
absence of AMP and the convergence of the curves to a similar point under saturating 
AMP concentrations. Wild-type phosphorylase b has a great deal of homotropic 
cooperativity in phosphate binding in the absence of AMP, but very little homotropic 
cooperativity in the presence of AMP. As given in equation 5.3, the ratio between these 
homotropic couplings in substrate binding affects the measured heterotropic coupling. In 
the case of the α-helix 1 mutants, the ratio is closer to unity due to the loss of 
homotropic cooperativity in the absence of AMP. Examination of the square root of the 
ratios of the homotropic coupling quotient in the presence and the absence of AMP for 
these mutants shows that they follow the same pattern as the differences in measured 
heterotropic cooperativity (Figure 5.6). It is then likely that the apparent changes in 
coupling between AMP and phosphate are actually a manifestation of the altered 
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Figure 5.6: Apparent heterotropic cooperativity and ratios of homotropic cooperativity in 
glycogen phosphorylase b wild-type, α-helix 1 and 280’s loop mutants. A) Heterotropic 
cooperativity between AMP and phosphate for α-helix 1 mutants and A19V. B) 
Heterotropic cooperativity between AMP and phosphate for 280’s loop mutants. C) 
Square root of the ratio of homotropic cooperativity for phosphate in the saturating 
presence of AMP and the homotropic cooperativity for phosphate in the absence of AMP 
for the α-helix 1 mutants and A19V. D) Square root of the ratio of homotropic 
cooperativity for phosphate in the saturating presence of AMP and the homotropic 
cooperativity for phosphate in the absence of AMP for the 280’s mutants. Ratios are a 
term that contributes to the apparent heterotropic cooperativity. 
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homotropic coupling, and the true heterotropic coupling may not be perturbed to any 
great extent. The ability to disconnect homotropic cooperativity from heterotropic 
coupling, particularly when that disconnection can come with either retention or loss of 
the homotropic cooperativity in AMP binding, indicates that AMP may have two distinct 
effects on phosphorylase b. One would bring about the homotropic cooperativity in 
AMP binding, and the other would activate the enzyme for catalysis. In wild-type 
phosphorylase b, these events are connected, but the fact that they can be disconnected 
shows that they are distinct from each other. If the changes in the packing of α-helix 1 
and 2 observed in crystallographic studies are, as has been proposed, the mechanism by 
which AMP affinity increases, then the repacking of α-helix 1 and 2 would be 
responsible for the homotropic cooperativity in phosphorylase b, but not the events that 
lead to activation. The finding here that activity can be measured without homotropic 
cooperativity in the absence of AMP indicates that the repacking of the interface need 
not take place for catalysis, and the observation that AMP can bind noncooperatively, 
but is still required for activation, indicates that even when the enzyme is predisposed to 
the shift of α-helix 1 and 2, it need not be active. This observation may help to explain 
why phosphorylase a, which is active in the absence of AMP, still shows a slight 
activation upon AMP binding. The phosphorylation event could have opened the active 
site, but AMP binding could still cause a slight rearrangement the active site causing 
further activation of the enzyme. 
A19V does not follow the pattern seen with the α-helix 1 mutants, probably due 
to A19 being on the N-terminus rather than in α-helix 1. The results observed with the 
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A19V mutant bears some resemblance to other mutants constructed to assess the 
functionality of the N-terminus (Chapter IV). The AMP saturated state of the enzyme is 
not perturbed, and the apo state of the enzyme is more like the activated species in its 
kinetic parameters. The reduced heterotropic coupling can simply be understood as the 
active form being more favored by the apo enzyme. This argument is supported by the 
finding that the homotropic effects track with changes in affinity. In other words, the 
initial decrease in AMP affinity is coupled to an increase in homotropic coupling in 
binding, and the enhanced affinity for phosphate is linked to a decrease in its cooperative 
binding. Similar results were observed with the mutations at position 16 in another study 
(Chapter IV,89). The distinct types of effects that mutations of the N-terminus and α-
helix 1 have indicate that these structural elements have distinct roles in the activation by 
AMP. 
This study has verified that the 280’s loop is involved in the allosteric activation 
of phosphorylase b by AMP. While it was beyond the scope of this study, the linking of 
the 280’s loop to the interface by the tower helix is probably critical for this activation. 
The other interface, namely the packing of α-helices 1 and 2, is important in the 
transmission of homotropic signals between the active sites and the allosteric sites, but 
that role is independent of the effect of AMP on the active sites. In wild-type, these 
effects are coupled to one another, but alterations of these helices can uncouple the 
homotropic and heterotropic effects.  
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CHAPTER VI 
CONCLUSIONS: A NEW PICTURE OF GLYCOGEN 
PHOSPHORYLASE  
 
 Much work has been done to unravel the complex regulation of glycogen 
phosphorylase with the major focus being on structural studies (1,8,13,71). Difficulties 
have been acknowledged in these studies, but a generally accepted structural model has 
emerged based on the two-state models of allostery (2,13). Accordingly, it has been 
proposed and generally accepted that the activated form of glycogen phosphorylase is 
the same whether that activation comes via phosphorylation or from the binding of 
AMP.  
 Glycogen phosphorylase served as part of the motivation in the development of 
the two-state models of allostery (27,28,29), but glycogen phosphorylase b kinetics 
cannot be described purely by the two-state systems (38,68,106). Alternate continuous 
models of allostery have been derived to explain the observed kinetics of wild-type 
phosphorylase b, but those models had never been tested despite the rather unexpected 
requirements predicted for activation (74,76,77). The application of linkage analysis to 
the phosphorylase system along with the perturbation of protein structure reported here 
has provided a wealth of new understanding of the allosteric communication. Using 
linkage analysis in combination with site-directed mutagenesis we have experimentally 
tested the continuous models of allostery in phosphorylase b, and we have examined the 
roles of the N-terminus, the 280’s loop, and α-helix 1 in allosteric activation by AMP.  
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MAJOR ADVANCES FROM THIS STUDY 
It is now shown that the continuous models of allostery for phosphorylase 
provide a fairly accurate representation of wild-type glycogen phosphorylase b activity, 
but are inadequate to describe the kinetics of phosphorylase b under all conditions 
(74,76,77). Glycogen phosphorylase b is active in the absence of AMP, though only at 
extremely high concentrations of phosphate. The bulk of activation by AMP binding 
takes place on the binding of the second equivalent of AMP to the dimer. The 
continuous models for phosphorylase were generated from wild-type data in the 
direction of glycogen synthesis rather than the physiological direction of glycogen 
breakdown (74, 76,77). Both models call for a requirement that substrate be bound to 
both active sites prior to catalysis. In this study, the phosphorylase reaction has been 
studied in the direction of glycogen degradation utilizing phosphate rather than glucose-
1-phosphate as the variable substrate. It is possible that two equivalents of AMP must be 
bound for the reaction in the direction of glycogen synthesis to take place, but in light of 
the findings presented here that becomes doubtful. 
 AMP activation of phosphorylase b does not require the presence of the N-
terminus. The N-terminus plays a role in establishing the affinity for phosphate and 
AMP in apo phosphorylase b. In the absence of the N-terminus the affinity for both is 
significantly diminished. Surprisingly, the binding of the N-terminus at the acidic patch 
on its own subunit appears to be the mechanism by which the N-terminus establishes the 
affinity for phosphate and AMP. Mutations that are expected to stabilize binding to the 
acidic patch enhance the affinity for AMP and phosphate in the apo enzyme, while 
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mutations that are expected to diminish the binding of the N-terminus to the acidic patch 
diminish the affinity for both AMP and phosphate.  
 It has been demonstrated here that the activation of phosphorylase by 
phosphorylation and AMP binding are not equivalent. Activation by phosphorylation is 
probably unique in that it directly involves three of the four structural units that make up 
the subunit interface (13). Phosphorylation occurs on the N-terminus which then 
relocates to the phosphoserine recognition site at the subunit interface thereby 
restructuring the interface. The binding of the phosphoserine at the subunit interface 
remodels α-helix 1, and directly interacts with residues of α-helix 2 as well as residues 
of the cap-loop. Along with an increase in affinity for phosphate and the loss of 
homotropic cooperativity in phosphate binding, the activation by phosphorylation 
includes an increase in Vmax (61,68). Activation by AMP does not result in an equivalent 
increase in Vmax indicating that there are differences at the active site between 
phosphorylase a and AMP activated phosphorylase b, a finding reinforced by differences 
in cofactor fluorescence between the two. 
 The 280’s loop has been proposed to have a role in the allosteric activation by 
AMP due to the finding that it blocks the active site from solvent in inhibitor bound 
structures (13,50). Unfortunately, structural work on phosphorylase has not provided any 
insight as to the role of the 280’s loop in the active enzyme. Modification of residues of 
the 280’s loop has demonstrated that the loop is important for catalysis, but the nature of 
that role remains undetermined (73). The apparent role in catalysis has prevented the 
definitive determination of any role in allostery.  
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 In this study, the 280’s loop is confirmed to have a major role in the allostery of 
glycogen phosphorylase. Mutations expected to disrupt the binding of the 280’s loop at 
the active site cleft disrupt the heterotropic communication between the AMP and 
actives sites. Of the structural units that have been modified in this study only the 
mutations affecting the 280’s loop demonstrated definitively that the heterotropic 
coupling had been disrupted. Unlike previous attempts to alter the 280’s loop, the 
alteration in heterotropic communication can be demonstrated without great loss of 
catalytic activity by altering the interacting partners of the 280’s loop (73). 
 The restructuring of subunit interface has been proposed to be important in the 
allosteric activation by AMP. Much attention has been given to the altered interactions 
of α-helix 2 and the cap-loop in the activated versus inhibited structures of 
phosphorylase, but little attention has been given to α-helix 1 (13,52,68). α-helix 1 has 
also been shown to have altered interactions between reported structural states, and 
sequence alignments have shown that residues are not conserved between the isozymes 
of phosphorylase (2,13). 
 In this study, α-helix 1 is shown to have a role in homotropic communication in 
phosphorylase b, but it does not appear to have a significant role in the heterotropic 
activation by AMP. The mutations in α-helix 1 disrupt the effect of phosphate binding 
on the homotropic cooperativity in AMP binding resulting in an enzyme species that 
shows homotropic cooperativity in AMP binding under all concentrations of phosphate. 
These mutants uncoupled the homotropic effects but do not alter the heterotropic effect. 
This result is similar to previous work done on the subunit interface by Robert Fletterick 
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that modified residue 48 on α-helix 2. AMP was shown to bind with high affinity and 
activated the enzyme but without homotropic cooperativity in AMP binding (68). 
 
Implications for the Structural Model of Activation: Based on the findings presented 
herein modifications must be made to the current structural understanding of 
phosphorylase activation. First, there is an implication that activation by phosphorylation 
and AMP binding are not equivalent. Structural work has seemed to support the notion 
that the active form of phosphorylase is the same regardless of the route of activation. 
However, it must be considered that the crystal structure of “active” phosphorylase b 
was solved with sulfate mimicking the phosphoryl group at position 14, and the resultant 
structure was very similar to the phosphorylated enzyme (51). The alternate structure 
solved without sulfate was intentionally solved under conditions that caused the protein 
to form a tetramer similar to that of phosphorylase a prior to crystallization (122). The 
enzymatically active form of phosphorylase is well established as a dimer, but the 
structure generally accepted as the active form of phosphorylase a and b were solved as 
a tetramer (11,13). The propensity of phosphorylase a to form a tetramer may indicate 
that it is physiologically relevant for the phosphorylated enzyme, but the hypothesis that 
the tetramer structure of phosphorylase b is the true active structure does not appear 
correct.  
 The work described here indicates at the very least that the active form of 
phosphorylase b need not be the same as that of phosphorylase a. The mechanism for 
activation of phosphorylase by phosphorylation has held up fairly well to testing (89). 
121 
 
The phosphoserine recognition site has been confirmed via mutagenesis, and the enzyme 
structure was solved as the form that persisted in solution indicating that for 
phosphorylase a it may indeed be a relevant structure (23). Inhibition of phosphorylase a 
typically comes about by binding inhibitors to the active site which occlude substrate, 
and stabilize the binding of the 280’s loop across the active site cleft (9,66,108). While 
typically referred to as stabilizing the T-state, such inhibitors do not cause the 
rearrangement of the α-helix 1 and 2 bundle to what is seen in apo phosphorylase b.  
 The data presented here are consistent with the hypothesis that the active form of 
phosphorylase b has the N-terminus located at the acidic patch. The implication is that 
the activation of phosphorylase b does not involve the movement of the N-terminus to 
the subunit interface. The rearrangement of the α-helix 1 and 2 bundle at the interface 
appears to be important for the transmission of the homotropic signal across the 
interface, but that is distinct from the transmission of the heterotropic activation to the 
active site. The alternate conformations are well established and are in part brought 
about by direct binding to AMP, indicating that the two conformations are relevant to the 
properties of phosphorylase (1,13). The combined finding that homotropic cooperativity 
in AMP binding can be retained or lost at all concentrations of phosphate indicates that 
the α-helix 1 and 2 bundle can be in either conformation for heterotropic activation to 
take place (68). 
 The 280’s loop plays an important role in activation by AMP. Whether that role 
comes from a simple occlusion of substrates from the active site, or if the binding of the 
280’s loop alters the structure of the active site itself cannot be resolved at this time. A 
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major question that remains is what role the 280’s loop plays in the active enzyme. 
Mutations to the 280’s loop have severe consequences on the activity of the enzyme 
indicating that the 280’s loop does have a role in the functional enzyme (73). It is 
speculated by the laboratory of Louise Johnson that the 280’s loop has a role in binding 
the polysaccharide substrate based on work done with MalP from E. coli (123), but 
beyond this the role of the 280’s loop is unknown for the active enzyme.  
 
AN ALTERNATE MODEL FOR PHOSPHORYLASE b 
Since repacking of the subunit interface alone is not enough to cause the 
activation of phosphorylase b, some other connection between the active site and the 
allosteric site must be critical in the activation by AMP. α-helix 8 (residues 289-312) 
potentially provides such a connection (Figure 6.1). α-helix 8 contains at its C-terminus 
the phosphoryl binding residues of the allosteric site. The N-terminus of α-helix 8 lies at 
the active site cleft and is poised to interact with both the 280’s loop and the base of the 
tower helix. This location provides a direct connection between the allosteric site, 
elements of the subunit interface, and the 280’s loop.  
 Therefore it is proposed that the binding of AMP to the allosteric site leads to 
changes in the packing of α-helix 8 which diminishes its interaction with the 280’s loop 
and the tower helix residues. The loss of a stabilizing interaction allows the 280’s loop to 
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Figure 6.1: α-helix 8 of glycogen phosphorylase. Subunit 1 is shown in light grey. 
Subunit 2 is shown in dark grey. AMP is shown in red. α-helix 8 which links to 
AMP site to the 280’s loop and tower helix is shown in forest green. AMP 
interacting residues side chains 309 and 310 highlighted. Tower helices are shown in 
yellow. Tyrosine 613 (purine inhibition site) and 280’s loop are shown in orange. 
Active site cofactor is shown in green. α-helices 1 and 2 on opposite face of enzyme 
are shown in pink (subunit 1) and blue (subunit 2). Structure from Protein Data Bank 
7gpb. Figure prepared using Chimera software. 
 
R309 and R310 
124 
 
dissociate from the active site cleft. The mutation of residue 287, which falls between α-
helix 8 and the 280’s loop, is one of the mutations that diminished the heterotropic 
interaction between AMP and phosphate, thereby supporting this hypothesis.  
 The dissociation of the 280’s loop from each subunit would allow for the 
movement of the tower helices. The tower helices sliding past each other on the release 
of the 280’s loop would account for the loss of homotropic cooperativity in phosphate 
binding upon AMP binding. The concerted movement of the tower helices would also 
explain why there is little heterotropic activation on the binding of a single equivalent of 
AMP. The tower helices must both move relative to each other to open the active site. 
Binding a single equivalent of AMP would release only a single 280’s loop, but that loop 
would be held in place by the tower helix until the second equivalent could bind 
allowing the tower helices to slide past each other.  
 In addition to its effect on the 280’s loop, the movements of α-helix 8 probably 
have a small effect directly on to the active site, explaining why the binding of a single 
equivalent of AMP to phosphorylase b caused a slight activation. Similarly, an effect 
transmitted by α-helix to the active site would provide an explanation of why 
phosphorylase a is activated by AMP to a similar extent as that seen on the binding of a 
single equivalent of AMP to phosphorylase b.   
 Binding of AMP involves residues of the cap loop and α-helix 2. In wild-type 
phosphorylase b these interactions would bring about the restructuring of the interface. 
These changes in conformation would be reinforced by the movement of the tower 
helices explaining how the homotropic cooperativity of both substrate and effector is 
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relieved in the presence of the other. These reinforcing effects can be lost by mutation as 
has been shown with mutations to α-helix 1. In the modified enzymes, the repacking of 
the interface is not expected to be as favorable. The binding of phosphate to the active 
site is no longer enough to bring about the repacking of the interface resulting in the loss 
of homotropic cooperativity in phosphate binding and the retention of AMP homotropic 
cooperativity at all concentrations of phosphate. It is important to note that the 
restructuring of the α-helix 1 and 2 side of the interface is only a reinforcing effect. 
Mutation of P48 showed the high affinity for AMP without homotropic cooperativity 
indicating that the interface was already in its high affinity conformation. AMP still 
showed its activating effect in this modified enzyme indicating that the altered 
conformation of the interface alone is not enough to activate the enzyme.  
 The essential argument of the structural model put forth here is that the binding 
of AMP differs from phosphorylation in how the signal is transmitted to the active site. 
In the case of phosphorylation the N-terminus is relocated to the subunit interface. This 
action carries with it the unique ability to simultaneously rearrange the entire interface. 
The conformation of the N-terminus is altered by its phosphorylation which also 
prevents its interaction with the acidic patch. The movement of the N-terminus alters the 
conformation of α-helix 1. The cap loop and α-helix 2 both provide residues to the 
phosphoserine recognition site. This complete restructuring of the interface presumably 
provides enough energetic input to slide the tower helices past each other and pull the 
280’s loop out of the active site cleft thereby activating the enzyme. 
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 By contrast, it is proposed here that the activation by AMP is the result of 
releasing the 280’s loop from the active site cleft by altering its interaction with α-helix 
8. Because the structural basis for activation is different, it is no surprise that the final 
state of the enzyme differs as is seen in the different Vmax for phosphorylase a. While it 
remains to be definitively proven that the allosteric signal is transmitted from the AMP 
binding site to the active site by α-helix 8, the model proposed herein provides a 
reasonable explanation of all the observations made to date.  
 
A FINAL NOTE ON THERMODYNAMIC LINKAGE 
Thermodynamic linkage provides a unique ability to quantify the interactions in 
an allosteric system (92, 93, 100, 101). There is no need to assume a model prior to 
analysis of the experimental data, and it provides a means to separate the various effects, 
that is homotropic and heterotropic, from one another. While thermodynamic linkage 
provides no structural information, it provides a means by which a structural hypothesis 
can be tested. As seen in this report, altering various structural units can have unique 
affects on the system as a whole. It would be impossible to interpret the results reported 
here by two-state models, but the utilization of thermodynamic linkage has allowed the 
resolution of the kinetic data to provide a clearer picture of allostery in phosphorylase b. 
This approach has been able to identify the roles of various structural units in the 
phosphorylase system and provided unique insights into how this system carries out its 
functions.   
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